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THE EFFECTS OF LEPTIN ON PLACENTAL DEVELOPMENT AND FUNCTION, 
AND OFFSPRING BEHAVIOR IN MICE 
Kelly E Pollock 
Dr. Laura Schulz, Dissertation Supervisor 
ABSTRACT 
 
The nutritional and energy status of individuals is communicated throughout the body by 
means of leptin. This hormone also plays a role in implantation and placental 
development and function, as well as programming behavior via alteration of brain 
function. The current research provides insight into how leptin is involved in placental 
and fetal development. The goal of the first study was to determine the importance of the 
leptin receptors of the mouse conceptus in placental development and function.  We 
utilized a leptin receptor knockout mouse model, and found significant alterations in gene 
expression in placentas lacking the receptor, suggesting that placental function may be 
altered. The goal of the second study was to determine the effect of maternal 
hyperleptinemia on offspring behavior. We compared wildtype offspring from two 
hyperleptinemic mouse models.  Adult offspring from hyperleptinemic dams weighed 
less, and were more active than their controls.  Female offspring from these dams 
consumed more food and had reduced preference for palatable food compared to their 
controls. Maternal hyperleptinemia during pregnancy protected offspring from weight 
gain by increasing activity. Overall, leptin affects placental gene expression, and possibly 
function, and offspring behaviors that influence energy homeostasis.  
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CHAPTER 1 
 
REVIEW OF THE LITERATURE 
 
1.1   Leptin 
 
 
1.1.1   Overview.   
Adipocytes produce a hormone referred to as leptin, which originated from the 
word leptós, meaning ‘thin’ in Greek (Halaas et al., 1995; Mustonen, 2003; Yang et al., 
2006). It has numerous functions involving: energy homeostasis (i.e. fat storage and 
usage, energy expenditure, satiety, etc.) (Kowalski et al., 2001), reproduction (i.e. embryo 
implantation) (Yang et al., 2006), puberty and cyclicity  (Ahima and Osei, 2004)) 
neuroendocrine pathways and brain development (Ahima and Osei, 2004), and immunity 
(Bernotiene et al., 2006). 
Leptin (Lep), though not yet named, was found to circulate in the blood through 
parabiosis experiments conducted by Coleman (1973).  In these experiments, a 
homozygous mouse with a mutation in either the ob (obese; leptin) or the db (diabetes; 
leptin receptor (Lepr)) gene was joined to the circulatory system of a wildtype mouse. 
This was done by attaching the skin of the mice from the shoulder to the hip. The 
inflammation at the suture sites promotes microvascular formation, thus connecting the 
circulatory systems of the two mice (Kamran et al., 2013). The celiac arteries, which 
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branch from the abdominal aorta, were also surgically connected (Coleman, 1973).  The 
Lepob/ob and Leprdb/db mice are diabetic and obese (Malik et al., 2001) due to hyperphagia, 
decreased energy expenditure, and increased conversion of calories into fat (Kowalski et 
al., 2001). They are also infertile and cold intolerant.  When the circulatory systems of 
Lepob/ob mice were linked to wildtype mice, the Lepob/ob mice ate less, lost weight and 
reversed all other symptoms.  When the circulatory systems of Leprdb/db mice were linked 
to Lepob/ob or wildtype mice, the Leprdb/db mice remained the same, while the Lepob/ob and 
wildtype mice lost significant amounts of weight (Coleman, 1973).  These results show 
that the ob gene encodes a circulating factor, leptin, which is necessary to maintain the 
lean phenotype, since the Lepob/ob mice seem to lack a circulating element, but obesity is 
reverse when it is introduced.  The db gene encodes a factor, leptin receptor, which 
responds to the circulating factor, since the Leprdb/db mice seem to produce a circulating 
element but cannot respond to it (Ahima and Osei, 2004; Mustonen, 2003).   
Another parabiosis study was conducted by Hervey using rats with lesions on the 
ventromedial nuclei of the hypothalamus (VMH) (Hervey, 1959). Rats with VMH lesions 
have obesity similar to the Lepob/ob and Leprdb/db mice. When VMH-lesioned rats were 
linked to the circulatory systems of wildtype rats, the VMH-lesioned rats maintained the 
obese phenotype, while the wildtype rats lost weight (Hervey, 1959). This is similar to a 
Leprdb/db mouse linked with a wildtype mouse.  These results imply that a circulating 
factor from the ob gene acts upon the db gene factor, which is located in the VMH 
(Ahima and Osei, 2004; Hervey, 1959).  
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1.1.2   Structure of the Gene, mRNA and Protein of Leptin and Its Receptors 
 Positional cloning was the technique used to discover the gene that encodes leptin 
in mice (Ahima and Osei, 2004; Zhang et al., 1994). In mice this gene is located on 
chromosome 6.  It is 13,656 base pairs in length and contains three exons (Bult et al., 
2008). The mRNA is 4.5 kb, which is transcribed into a 167 aa long polypeptide (Ahima 
and Osei, 2004). The N-terminus is cleaved, resulting in a 146aa circulating protein 
(Mustonen, 2003). The structure of the leptin protein is similar to those in the “long-chain 
helical cytokine family,” in that it has a group of four alpha-helices (Zhang et al., 1997).  
The mouse ob gene was used to create leptin probes that were employed to 
discover the human homolog, which is located on chromosome 7 (Green et al., 1995). 
The protein coding region of the human OB gene is very similar to the mouse sequence, 
but only ~30% of the 3’-untranslated region is the same (Green et al., 1995). The human 
mRNA for leptin is similar in size and the protein is an 84% match to the mouse (Zhang 
et al., 1994). 
 The gene encoding the leptin receptor (Lepr) in the mouse is located on 
chromosome 4 and is 97,949bp in length (Bult et al., 2008). The LEPR gene is located on 
chromosome 1 in humans (Thompson et al., 1997). There are six known transcripts 
produced through alternative splicing from human, mouse and rat lepr genes denoted 
Lepr-a through f (Bernotiene et al., 2006). Lepr-a, Lepr-b and Lepr-c are the only 
transcripts that have been found in humans. However there is a soluble Lepr-e protein, 
which is produced by cleaving the other receptors (Maamra et al., 2001). Rats and mice 
have Lepr-a,b,c and e; Lepr-f has only been found in rats and Lepr-d only in mice 
(Bernotiene et al., 2006).  
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The leptin receptor proteins are classified as part of the class I cytokine receptor 
family (Kowalski et al., 2001). All of the Lepr isoforms have identical ligand binding 
(extracellular) and transmembrane domains, except for Lepr-e, which lacks the 
transmembrane domain (Kowalski et al., 2001). Differences occur in the cytoplasmic 
(intracellular) domain.  The longest isoform, Lepr-b, has both Janus kinase (JAK) and 
signal transducer and activator of transcription (STAT) binding motifs (Kowalski et al., 
2001). The shorter isoforms only have the JAK binding motif, except Lepr-e, which lacks 
this domain (Kowalski et al., 2001).   
Leptin binds to its receptor at the “cytokine receptor homology module 2 (CRH 
2)” on the extracellular domain (Bernotiene et al., 2006). Once it is bound, a 
phosphorylation event activates the JAK2 pathway, which causes the phosphorylation of 
tyrosine-1138 (Bahrenberg et al., 2002). Then STAT transcription factors (i.e.  STAT3 
and STAT5) bind and become active by means of phosphorylation (Bahrenberg et al., 
2002; Kowalski et al., 2001). Transcription at specific promoters is then stimulated in that 
cell/tissue (Bahrenberg et al., 2002). These events have only been observed with 
homodimers of the Lepr-b isoform (Bahrenberg et al., 2002). Lepr-a and Lepr-c isoforms 
may be involved in the transportation of leptin (McMinn, 2003). 
1.1.3   Expression of Leptin and Its Receptors.  
 Leptin circulates through the blood and is removed by the kidneys in rats (Cumin 
et al., 1996).  Adipose tissue is the main source of leptin production (Ahima and Osei, 
2004), but other tissues have been found to produce the protein as well: stomach 
epithelium (rats) (Bado et al., 1998), brain and pituitary (rats) (Morash et al., 1999), 
placenta (in humans, but not rodents) (Masuzaki et al., 1997), fetal cartilage, bone and 
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hair follicles (mice) (Hoggard et al., 1997), and skeletal muscle (mice) (Wang et al., 
1998).  
Leptin receptors Lepr-b and Lepr-a have both been found to be omnipresent, 
although Lepr-a is more highly expressed in most tissues (Kowalski et al., 2001), 
especially the kidneys and liver (McMinn, 2003).  Brain microvessels contain high 
quantities of the Lepr-a and Lepr-c isoforms, which may indicate that they are involved 
in the transportation of leptin (McMinn, 2003). The soluble form of the leptin receptor, 
Lepr-e, circulates and can bind leptin.  In organisms that are of normal body weight, the 
receptor binds around 50% of leptin (McMinn, 2003). The Lepr-b isoform makes up 35% 
of the leptin receptors produced in the hypothalamus (Kowalski et al., 2001). It is 
specifically expressed in the arcuate nucleus (ARC), which is associated energy with 
homeostasis (McMinn, 2003). Knowing the function and expression pattern of the leptin 
receptors may lead to therapies for human health concerns, such as obesity. Leptin could 
be a potential target for treatment during pregnancy for obese or diabetic women to help 
prevent or reduce their children’s predisposition for obesity. 
1.1.4   Regulation of Leptin.  
The quantity of leptin, in organisms that are on an ad libitum diet, corresponds to 
the amount of adipose tissue present. This means that an increase or decrease in fat tissue 
results in a proportional increase or decrease in leptin production (Frederich et al., 1995).   
Amount of fat is not the only regulator of leptin. Fasting results in decreased 
leptin levels that are disproportional to the amount of adipose tissue lost. On the other 
hand, eating results in a rise in leptin within hours (Saladin et al., 1995). Insulin has also 
been shown to regulate leptin; insulin stimulates leptin production in vitro, in mouse 
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adipocyte cultures, and in vivo (Rentsch and Chiesi, 1996; Saladin et al., 1995). Steroids, 
such as glucocorticoids, and infections can also affect leptin production (Ahima and Osei, 
2004). 
In both mice and humans leptin levels are highest at night and wane during the 
day, and insulin may regulate this pattern (Ahima and Osei, 2004). Fasting prevents the 
leptin peak, and night fasting combined with daytime eating causes leptin to peak during 
the day in mice (Ahima and Osei, 2004). In humans, this diurnal rhythm is reduced in 
older adults, and is associated with increased fat accumulation and insulin resistance 
(Ahima and Osei, 2004).  Leptin is released in a pattern of pulses throughout a 24-hour 
time period. The pattern is similar between males and females, but females have higher 
peaks (Ahima and Osei, 2004).  
1.1.5   Models for Leptin Research.  
The Lepob/ob mouse, mentioned above, is one of several mouse knockout models 
that have been used to study leptin and its receptors. They have a mutation that gives rise 
to a premature stop codon, thus creating a truncated protein that is degraded.  This mouse 
model is often used in leptin research. Another knockout model is the Leprdb/db mouse, 
also mentioned above, which has a mutation in the gene that encodes the leptin receptor 
(Figure 1). The mutation in the Lepr gene of Leprdb/db mice causes a defect in mRNA 
splicing.  The receptor isoform b has a segment added to it that has a stop codon at the 
end, causing it to be converted to isoform a, thus preventing the production of isoform b.  
All other isoforms are present (McMinn, 2003).  These mice have the same 
characteristics as the Lepob/ob mice (Malik et al., 2001).  This means that the long receptor 
isoform, Lepr-b, is very important in controlling the balance of energy (McMinn, 2003).   
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A model that is similar to the Leprdb/db mouse is the Leprdb3j/db3j mouse knockout 
model, which has a mutation in the gene encoding the leptin receptor that causes a 17bp 
deletion in exon 11 (Figure 1). This causes the protein to become truncated 11 amino 
acids after the deletions, thus preventing the production of any known isoforms (Lee et 
al., 1997). These mice have the same characteristics as the Lepob/ob and Leprdb/db mice 
(Kowalski et al., 2001). 
Mice that are heterozygous for the leptin receptor have been used for studying 
leptin’s role in reproduction and as a model for gestational diabetes militias (GDM). The 
Leprdb/+ mouse is not well defined as a model for gestational diabetes in women, even 
though it is considered one.  Few studies have been conducted that look at gestational 
diabetes in these mice, and they have some conflicting findings.  There may be multiple 
factors that contribute to the onset of gestational diabetes mellitus in the heterozygous 
Leprdb/+ mice, including the amount of fat in their diet during pregnancy, and number of 
previous pregnancies. In one study Leprdb/+ females were mated at age 60 to 70 days old 
to Leprdb/+ males. The percent fat in the diet during pregnancy was not reported.  At day 
18.5 of pregnancy the females underwent an overnight fast followed by a glucose 
tolerance test. Fasting glucose levels were higher in the Leprdb/+ females and they had 
reduced glucose clearance compared to Lepr+/+ females, which indicates that they are 
significantly more glucose intolerant (Ishizuka et al., 1999). Insulin levels were also 
measured, but weren’t significantly different. Leptin was measured and was significantly 
higher in Leprdb/+ females before and during pregnancy compared to the Lepr+/+ females 
(Ishizuka et al., 1999), which may indicate a predisposition for diabetes. Pups born to 
Leprdb/+ females were larger than their Lepr+/+ counterparts (Ishizuka et al., 1999).  Two 
8 
 
other studies from the same lab found similar differences using slightly different 
protocols. In both, females were mated at 60 to 80 days of age, and they were fasted for 
six hours. In the first study the percent fat in the diet was not indicated and Lepr+/+ males 
were used for breeding (Yamashita et al., 2001), while the second used a 19% kcal from 
fat diet (according to the diet data sheet) and Leprdb/+ males were used for breeding 
(Yamashita et al., 2003a). Another lab conducted studies in these mice and found no 
difference in glucose at gestational day 18 between Leprdb/+ and Lepr+/+ females 
following an overnight fast. The females were at least 56 days old when mated to Lepr+/+ 
males and they were on a three percent (by weight) fat diet (Lambin et al., 2007).  The 
Lamping group found no differences in basal glucose levels or glucose tolerance of 
pregnant Leprdb/+ females compared to controls when on a 13 to 18% kcal from fat diet. 
They put some females on a 45% from kcal fat diet and the Leprdb/+ females didn’t differ 
in their fasting glucose compared to the Lepr+/+ females, but they had reduced glucose 
clearance (Harrod et al., 2011). This study also looked at glucose tolerance in 
multiparious and older females, but they saw no differences (Harrod et al., 2011). Taken 
together, it is unclear what conditions are necessary to induce GDM in the Leprdb/+ mice. 
A controlled study looking at multiple parameters (percent fat diets, parity, age, etc) 
using the same procedures (fasting period, age at testing, amount of glucose, etc) is 
necessary to determine how to effectively use Leprdb/+ as a model for GDM. 
Another mouse model developed to study leptin is the Leprflox/flox mouse. Exon 17 
of the leptin receptor gene in these mice is flanked by loxP sites, which can be used to 
remove this section of the gene by using Cre recombinase (Balthasar et al., 2004). When 
exposed to Cre, exon 17 is removed, causing a frame shift starting at the last nucleotide 
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of exon 16 that creates a premature stop code in exon 18 (Figure1). The leptin receptor 
protein is no longer produced.  Leprflox/flox mice not exposed to Cre have the same 
phenotype as wild type mice (Balthasar et al., 2004). These mice are used for conditional 
deletions of the leptin receptor. For example, a study was conducted using the Cre/loxP 
system for a tissue specific knockout.  They used a POMC (neuron) promoter to control 
the expression of Cre recombinase, thus only POMC neurons lacked the leptin receptor, 
due to the exon 17 deletion (Balthasar et al., 2004). This resulted in mild obesity, 
increased leptin levels, and altered expression of hypothalamic neuropeptides (Balthasar 
et al., 2004). 
 
Figure 1 Leptin Receptor Knockout Models 
1.1.6   Leptin and Energy Homeostasis.  
As previously mentioned, one of the primary roles of leptin is to maintain energy 
homeostasis. It acts as a satiety factor through Lepr-b signaling in the hypothalamus. The 
arcuate nucleus (Arc) is a region of the hypothalamus that contains neurons that express 
orexigenic or anorexigenic factors that regulate food consumption.  Neuropeptide Y 
(NPY) and Agoui-related protein (AgRP) are coexpressed in neurons in the Arc and 
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stimulate food consumption.  Conversely, Proopiomelanocortin (POMC) and cocaine- 
and amphetamine-regulated transcript (CART), which are also coexpressed in neurons in 
the Arc, both inhibit food consumption (Elias et al., 1999). Both types of neurons also 
express leptin receptor b. Leptin levels increase with food consumption and/or increased 
body fat, which inhibits the orexigenic NPY/AgRP pathway and stimulates the 
anorexigenic POMC/CART pathway (Sahu, 2004). This effectively signals for the 
cessation of food consumption. Leptin also affects energy storage and expenditure; 
increased leptin levels signal for a decrease in energy storage and an increase in energy 
expenditure (Pelleymounter et al., 1995). 
Less is known about the function of the short isoforms of the leptin receptor. A 
Lepr-a knockout mouse was developed to try to fill this knowledge gap. The Lepr-a 
knockout mice are slightly more glucose tolerant and have decreased fasting glucose, and 
when on a high fat diet they have slightly increased fat mass and body weight (Shichida 
and Yamashita, 2003). It is has previously been suggested that Lepr-a may act as a 
transporter of leptin across the blood-brain barrier. When Lepr-a knockout mice are 
challenged with a high fat diet, there is a reduction of leptin in the cerebrospinal fluid, 
which supports that hypothesis (Shichida and Yamashita, 2003). Lepr-b and c are 
upregulated in the Lepr-a knockouts and likely compensate for the loss, so it is difficult to 
make  definite conclusions about its function (Bolton et al., 2003). 
The soluble form of the leptin receptor, Lepr-e, acts as a binding protein for 
leptin. It can inhibit leptin action by preventing leptin from binding to its membrane 
bound receptors. On the other hand, it can decrease leptin’s clearance time and increase 
its availability (Takahashi et al., 2003).  
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1.2   Leptin and Reproduction 
 
Leptin communicates the energy status of an individual to the body. When sufficient 
energy is not available (i.e. food supply, fat stores) leptin is low which signals the body to 
conserve energy. Reproductive processes, such as puberty, menstrual/estrus cycles, and 
pregnancy require a certain amount of energy. Females who have low body mass due to 
excessive exercise or insufficient food consumption often have delayed puberty, 
amenorrhea and fertility problems (Donato et al., 2011). Obesity, a state of excess energy, 
is associated with increased circulating leptin levels and reproductive complications such 
as infertility, but this is likely due to leptin resistance (Kitahara et al., 2003). Obese 
individuals also have reduced circulating Lepr-e and only 20% of leptin is bound, instead 
of 50% (McMinn, 2003). 
1.2.1 Implantation and Placentation.  
To establish the vital communication between mother and fetus, implantation and 
placentation must occur successfully. Implantation provides the foundation for placental 
development. Therefore, if implantation does not occur properly, the subsequent 
placental development will be adversely affected. A properly functioning placenta is 
necessary to regulate the transfer of nutrients from the mother to the fetus, and leptin 
likely plays a role in that system of regulation. 
1.2.1.1   Mice. Implantation in mice is invasive and similar to human 
implantation. After a blastocyst enters the uterus and hatches it becomes oriented on the 
antimesometrial side of the uterus with the inner cell mass (ICM) toward the mesometrial 
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side (Bazer et al., 2009). After mating, maternal progesterone levels increase, which 
causes Muc-1, a mucin that lines the uterine epithelium, to be lost, allowing the 
blastocyst to attach (Bazer et al., 2009). The outer-layer of cells, the trophectoderm, of 
the embryo invades into the endometrium of the uterus (Hoegh et al., 2010). The uterus 
folds around the embryo, encapsulating it. Decidualization then occurs, and trophoblast 
giant cells invade in to the decidua and maternal vasculature (Bazer et al., 2009). This 
interferes with the musculature and elasticity around them (Hoegh et al., 2010).  The 
vessels become dilated and less resistant to blood flow, due to their inability to constrict, 
thus supplying a sufficient amount of blood to the placenta (Hoegh et al., 2010).An 
ectoplacental cone is formed by the rapid proliferation of trophoblast cells. Stem cells, 
contained within the ectoplacental cone, engender the other trophoblast lineages; 
syncytiotrophoblasts and giant cells (Hoegh et al., 2010).  Around day 9.5 of pregnancy, 
the allantois fuses with the chorion and the labyrinth layer develops. This layer is where 
fetal blood vessels come in contact with maternal blood (Cross et al., 1994) and is the site 
of nutrient, gas and waste exchange. There is also a junctional zone that is between the 
decidua and labyrinth, which has endocrine functions (Cross et al., 1994).  
1.2.1.2   Humans. The human conceptus is even more invasive than the mouse 
conceptus. The ICM is oriented toward the uterine wall unlike the mouse. The embryo 
attaches to the uterine epithelium, syncytialization of the trophoblast cells occurs, and the 
embryo migrates into the uterine wall. By gestational day 21 chorionic villi are formed. 
They anchor the placenta and are within in the intervillous space where they are bathed in 
maternal blood; this is the site for the exchange of nutrients, gas and waste (Malassine et 
al., 2003). Stem cells, contained within the villi, engender the other trophoblast lineages; 
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syncytiotrophoblasts and extravillous cytotrophoblasts (Hoegh et al., 2010).  
Syncytiotrophoblasts fuse and cover the surface of the villi (Malassine et al., 2003). 
Extravillous trophoblasts invade into the decidua, maternal blood vessels and 
myometrium (more invasive than in mice). This prevents the blood vessels from 
constricting, which allows for unrestricted blood flow (Malassine et al., 2003). 
1.2.2   Leptin during Pregnancy.  
During pregnancy plasma leptin levels increase in both mice and humans. In mice 
the levels begin to increase significantly at gestational day 11 and peak at day 17 
(Tomimatsu et al., 1997). In humans leptin levels increase during the first two trimesters 
and plateau at the end of the second or beginning of the third trimester, and are two to 
three-fold higher than in the nonpregnant condition (Kitahara et al., 2003; Miehle et al., 
2012). After delivery of the offspring, leptin returns to pre-pregnancy levels in mice and 
humans (Kitahara et al., 2003; Tomimatsu et al., 1997). It has been shown in the rat that 
the high leptin levels lead to down regulation of Lepr-b in the hypothalamus, where 
appetite is controlled by leptin, and increased Lepr-e, which binds leptin. This results in 
central leptin resistance, which may be necessary to insure adequate  energy availability 
for fetal growth and development (Kitahara et al., 2003).  
1.2.2.1 Implantation. Malik and others (2001) conducted a key experiment that 
demonstrated leptin as a crucial element involved in implantation. The Lepob/ob mouse 
was used in the study because it completely lacks circulating leptin, but retains the 
receptors. These mice are obese and infertile, but the phenotype can be reversed with 
exogenous leptin injections. In the study, these mice were supplemented with leptin, 
mated, and then leptin supplementation was removed at gestational day 0.5, 3.5, 6.5, 14.5 
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or continued through parturition. Females that were taken off leptin at day 0.5 or 3.5 
failed to remain pregnant. When leptin was removed after this point, the pregnancy went 
to term; however the offspring died postnatally, due to lack of mammary gland 
development in the dams, unless leptin administration was continued throughout 
pregnancy. Implantation in mice occurs between day 4.5 and 5.5 (Yoon et al., 2005); thus 
the results indicate that leptin is essential for pre-implantation and/or implantation itself 
(Malik et al., 2001).  A more recent study similarly implicated leptin as a significant part 
of implantation. Leptin peptide antagonists, which block leptin activity, were directly 
injected into the uterus of pregnant mice on day 3 and this inhibited implantation (Ramos 
et al., 2005). These two studies show that leptin plays an important role in the 
implantation process. 
The leptin receptor is expressed in the endometrium and embryo, the two key 
components involved in implantation. There is a pattern of leptin receptor expression 
throughout the menstrual cycle of women, but there is discrepancy over what that pattern 
is (Cervero et al., 2005).  One research group published evidence demonstrating leptin 
receptor expression peaking during the early secretory phase (Kitawaki et al., 2000).  In 
contrast, other groups indicated that leptin receptor expression was low during the early 
secretory phase and elevated during the proliferative and/or late secretory phases (Alfer et 
al., 2000; Cervero et al., 2004).   All of the studies show expression of the receptor in the 
endometrium during the window of implantation (Cervero et al., 2005). One study found 
that in mice the leptin receptor is down regulated at implantation sites when compared to 
interimplantation sites (uterine area between implantation sites), and that it is more highly 
expressed in stromal tissue versus luminal epithelium (Yoon et al., 2005). In conjunction 
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with other embryonic factors, it has been suggested that embryonic estrogen may be 
involved in the regulation of leptin receptor expression (Yoon et al., 2005). The leptin 
receptor is found in pre-implantation embryos, including the trophectoderm of the 
blastocyst (Cervero et al., 2005), although embryos lacking leptin receptor (Lepdb/db) are 
viable. 
1.2.2.2   Placenta. In humans, but not mice, the placenta produces leptin and is a 
major contributor to the high levels of leptin during pregnancy (Kitahara et al., 2003). 
Placental leptin production has been shown to be increased by human chorionic 
gonadotropin (hCG), which is secreted by synciotrophoblasts, and estradiol-17β (E2) 
(Kitahara et al., 2003). 
 Leptin has been shown to affect nutrient transport in the placenta. It stimulates 
System A sodium dependent neutral amino acid transport (SNAT) activity in human 
placental explants (Jansson et al., 2003). Activity of SNAT is decreased in the 
syncytiotrophoblasts of pregnancies complicated by intrauterine growth restriction, and 
increased in pregnancies complicated by diabetes, which have high leptin levels, and 
result in large for gestational age fetuses (Jansson et al., 2003; Jansson et al., 2002). 
SNAT activity in pregnancies complicated by obesity, which also have high leptin levels, 
is decreased (Farley et al., 2010).  Although it is still unclear what regulates SNAT 
activity, leptin may play a role, since altered placental SNAT activity and leptin activity 
seem to be associated.   
Angiogenesis has been shown to be stimulated (Sierra-Honigmann et al., 1998) or 
blocked by leptin (Islami et al., 2003). The angiogenic factor C1qtnf6 is upregulated in 
food restricted mice treated with leptin (Schulz et al., 2012). Vascular endothelial growth 
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factor (VEGF) secretions, which promote vascularization, are decreased by leptin (Islami 
et al., 2003).  Arterial vascular smooth muscle cell growth is reduced by leptin in vitro 
(Bohlen et al., 2007). Impaired placental vascularization was found with decreased levels 
of fetal leptin (Huppertz et al., 2007), while another study showed no difference in 
placental vascularization in women with type 1 diabetes and increased fetal leptin levels 
(Nelson et al., 2009). The latter study is supported by another study that found no 
correlation between leptin and placental vascularization in sheep (Forhead et al., 2008). 
The precise function of leptin in angiogenesis is still unclear. 
Leptin’s affect on cell growth and survival is not excusive to vascular tissue. 
Trophoblast cell proliferation is stimulated by leptin in vitro and apoptosis is inhibited 
(Magarinos et al., 2007). Synthesis of DNA and protein in cultured trophoblast cells is 
also stimulated by leptin (Perez-Perez et al., 2010). Leptin, therefore, is important for 
placental growth in general.  
1.2.3   Leptin’s role in Pregnancy Related Disorders 
Maternal obesity, Gestational Diabetes Mellitus (GDM) and pre-eclampsia are all 
associated with high levels of leptin in the maternal circulation (Cervero et al., 2006; 
Kautzky-Willer et al., 2001; Matsumoto et al., 2003). 
1.2.3.1 Obesity. Obesity is a major problem in developed and developing 
countries. Metabolic syndrome, which causes six to seven percent of all deaths (Ford et 
al., 2010; Ono et al., 2005; Rinaudo and Wang, 2011), is associated with obesity and 
includes health issues such as diabetes, cardiovascular disease and non-alcoholic fatty 
liver disease (Ahima and Lazar, 2013). Despite having high leptin levels, obese 
individuals do not have reduced food intake or increased energy expenditure, suggesting 
17 
 
that they are leptin resistant (Myers et al., 2010). In the United States over one-third of 
men and women were reported to be obese in 2011 to 2012 by the CDC (Ogden et al., 
2013). Obesity is also a risk factor for reproductive dysfunction. Obese women of 
reproductive age have a higher incidence of polycystic ovary syndrome, and miscarriage 
(Guelinckx et al., 2008). Maternal obesity increases the risk of still birth and perinatal 
death, as well as macrosomia, which can lead to dystocia.  Macrosomic offspring are 
more likely to become obese and/or diabetic (Guelinckx et al., 2008).  Women who are 
obese during pregnancy have increased risk for hypertension, GDM and preeclampsia 
(PE) (Guelinckx et al., 2008).  
In a normal pregnancy, leptin and Lepr-e levels increase, resulting in more bound 
leptin, which may be the cause of  central leptin resistance (Kitahara et al., 2003). 
Pregnancies complicated by obesity are associated with higher levels of leptin and lower 
levels of Lepr-e compared to normal pregnancies, resulting in mostly unbound leptin 
(Ogier et al., 2002). The high levels of unbound leptin may cause the down regulation of 
Lepr-b in the placenta, due to negative feedback, resulting in placental leptin resistance 
(Farley et al., 2010; Tessier et al., 2013). Suppressor of cytokine signaling 3 (SOCS3), in 
addition to leptin, negatively regulates leptin receptor signaling. When leptin binds to its 
receptor it results in STAT3 triggering SOCS3 transcription, and SOCS3 is part of a 
negative feedback loop for leptin (Bjorbaek et al., 1999). 
1.2.3.2 Gestational Diabetes Militias. Two to five percent of pregnancies are 
affected by GDM, glucose intolerance due to insulin resistance (Gilmartin et al., 2008). 
Gestational diabetes increases the risk of complications for the fetus, including: 
macrosomia, respiratory distress syndrome, and hypoglycemia. Long-term effects on the 
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offspring consist of increased risk of obesity, childhood diabetes, impaired motor 
function, and attention deficit hyperactivity disorder (Gilmartin et al., 2008; Ornoy et al., 
1998).  Women with GDM are at higher risk for urinary tract and kidney infections, pre-
term labor, postpartum type 2 diabetes and preeclampsia (Gilmartin et al., 2008). 
Gestational diabetes is associated with increased circulating leptin and Lepr-e 
compared to normal pregnancies (Kautzky-Willer et al., 2001; Lewandowski et al., 
1999). High maternal and amnionic fluid leptin levels during early/mid pregnancy may 
predict an increased risk for developing GDM (Miehle et al., 2012).  Inflammation is also 
associated with GDM, indicated by an increase in tumor necrosis factor alpha (TNFα) 
and interleukin 6 (IL-6), both of which stimulate and are stimulated by leptin, creating a 
vicious cycle. Tumor necrosis factor alpha may be related to insulin resistance, 
contributing further to the diabetic condition (Miehle et al., 2012). Insulin is usually 
administered to women with GDM to control glucose levels, which may exacerbate the 
hyperleptinemia, because leptin is stimulated by insulin (Miehle et al., 2012). 
 
The fact that leptin is elevated with maternal obesity and GDM suggests that it plays a 
role in either the etiologies of the disorders or perhaps as a compensatory or protective 
mechanism. Offspring from mothers with these disorders are predisposed to obesity 
and/or diabetes (Gilmartin et al., 2008; Guelinckx et al., 2008). Because of leptin’s 
function in energy homeostasis, it is reasonable to propose that leptin could contribute to 
that predisposition.  
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1.3   Leptin and Fetal Programming 
 
1.3.1  Developmental Origins of Health and Disease 
 
Developmental Origins of Health and Disease (DOHaD) and fetal programming 
are the current terms for the hypothesis put forth by Barker et. al (1986), stating that 
conditions during prenatal life affect adult health. This idea came about when Barker and 
his colleagues observed a paradox concerning the rates of ischemic heart disease in 
England and Wales. As people became more affluent, rates of the disease increased, but 
the highest incidences occurred in the low income areas (Barker and Osmond, 1986).  To 
further investigate this hypothesis, Barker and colleagues conducted a retrospective study 
looking at the birth and one-year weights of males born between 1911 and 1930 in a 
section of Hertfordshire, England. They found that males with a lower than average birth 
and one-year weights had high incidences of ischemic heart disease as the cause of death 
(Barker et al., 1989). Many more studies were done supporting the “Barker Hypothesis,” 
but it still received criticisms. One of the major concerns was the use of birth and one-
year weights as measures of prenatal and postnatal nourishment.  Other factors can 
influence these weights, such as maternal health, smoking habits, and social class (Paneth 
and Susser, 1995).   
One particular cohort of births lent itself to effectively test whether prenatal 
nutrition increases the risk of adult disease: the Dutch Hunger Winter cohort.  In the 
winter and spring of 1944 to 1945 in the western region of the Netherlands, food was 
rationed by the German occupation due to a railway strike. All of the people in the 
region, regardless of social class, were restricted to 400 to 800 calories per day, including 
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pregnant women (Schulz, 2010). When the war and famine ended prosperity followed.  
The children born around this famine have provided crucial data for testing and 
supporting the “Barker Hypothesis” and providing a foundation for DOHaD research 
(Schulz, 2010).   
One study of this cohort traced a group of individuals born between November 
1943 and February 1947 in Amsterdam (Roseboom et al., 2006). They were grouped 
according to when they were exposed to the 13 weeks of famine. There were those 
exposed during early, mid or late gestation or unexposed. Those considered unexposed 
were born before or conceived after the famine. During the famine the rations for 
children were never below recommended amounts (Roseboom et al., 2006).  They 
evaluated individuals at ages 50 and 58 and found all who were exposed, no matter the 
stage pregnancy, had higher glucose and insulin levels compared to those who were 
unexposed.  Birth weights were reduced in those exposed during mid and late gestation, 
but were normal in those exposed during early gestation. Undernutrition during mid 
gestation affected kidney function and bronchial development, while the ratio of 
carbohydrates and protein during late gestation affected adult blood pressure. Exposure to 
the famine during early gestation was correlated with a more atherogenic plasma lipid 
profile, increased fibrinogen levels and higher incidence of coronary heart disease (CHD) 
(Roseboom et al., 2006).   Females who were conceived during the famine had higher 
BMIs compared to the other groups, and a high incidence of breast cancer. The fact that 
early gestational exposure to restricted nutrition resulted in increased adult health 
problems, but normal birth weights, shows that birth weight is not a good measure of 
prenatal nutrition or predictor of adult disease. Taken together, these findings indicate 
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that maternal undernutrition during pregnancy can affect the adult health of their children 
and the exposures during different developmental periods have different effects 
(Roseboom et al., 2006).  
1.3.2     Leptin and Programming of Offspring Behaviors 
Fetal programming is not limited to maternal undernutrition. As previously 
discussed, maternal obesity and GDM have been found to predispose offspring to obesity 
and diabetes (Dabelea et al., 2000b; Drake and Reynolds, 2010).   A study of nearly 
3,200 mother-child pairs in Amsterdam found that maternal pre-pregnancy BMI was a 
major independent determinant of child weight and BMI at 14 months of age (Mesman et 
al., 2009).  Another study of nearly 8,500 low-income mother-child pairs in the U.S. 
showed that maternal obesity increased the risk of children at ages 2 to 4 years of 
becoming obese (Whitaker, 2004). Approximately 10,000 mother-child pairs in the U.K. 
and Western U.S. were studied, demonstrating that children born to mothers with GDM 
had an increased risk for childhood obesity (Hillier et al., 2007; Lawlor et al., 2010). 
Studies of the Pima Indian population show  that diabetes during pregnancy is a major 
risk factor of childhood obesity, which is clearly shown in sibling comparisons when one 
is born before maternal diabetes and the other born after (Dabelea et al., 2000a; Dabelea 
et al., 2000b). The uterine environment also affects offspring behaviors, which may 
contribute to the development of childhood and adult obesity.  
Food consumption and preference can be altered in offspring who were affected 
by maternal obesity, over nutrition or diabetes (Brion et al., 2010; Kirk et al., 2009; Ong 
and Muhlhausler, 2011; Vucetic et al., 2010; Walker et al., 2008).  A prospective study of 
more than 5,500 mother-child pairs and >3,000 father-child pairs demonstrated a strong 
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association of maternal prenatal diet to the child’s diet at age 10 compared to maternal 
postnatal diet and paternal diet.  Maternal prenatal consumption of fats, proteins and 
carbohydrates was positively correlated to child consumption of the same macronutrients 
(Brion et al., 2010). In other words, mothers who consumed more fat during pregnancy 
had children who consumed more fat at age 10, which suggests that offspring feeding 
behaviors may be affected by maternal prenatal nutrition and could increase their risk of 
obesity. Similar results have been seen in animal studies. One study in rats found that 
offspring from dams fed an obesogenic diet before conception, during pregnancy and 
lactation were hyperphagic and obese (Kirk et al., 2009).  Another rat study observed an 
increase in food intake and a preference for high fat foods in offspring exposed to a 
maternal high fat diet from the last week of gestation through lactation (Walker et al., 
2008).  Ong and Muhlhausler (2011) investigated the effect of maternal ‘junk-food’ diet 
on offspring food preference and neurological alterations to the central reward pathways. 
They found that rat offspring from mothers on a ‘junk-food’ diet (preconception through 
lactation) consumed more fat as juveniles and adults. The mesolimbic reward pathway is 
also altered in the offspring.  Juveniles from dams fed a ‘junk-food’ diet had increased 
opioid and dopamine sensitivity which increases their preference for high-fat foods. 
When the juveniles became adults, the reward pathway became desensitized, due to 
continued fat consumption, and augmented their preference for high-fat foods (Ong and 
Muhlhausler, 2011).  Vucetic et al. (2010) also found alterations in the mesolimbic 
reward pathway, which increased preference for palatable foods, of offspring exposed to 
maternal high-fat diet during gestation and lactation, and that the alterations were due to 
hypomethylation of related promoters in the brain.  
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Complimentary to energy intake, energy expenditure is an important component 
when looking at predisposition to obesity. Energy is expended in many ways including 
reproduction, basal metabolic rate, digestion and food processing, and thermoregulation 
(Garland et al., 2011).Two other ways to expend energy are voluntary/volitional exercise 
and spontaneous physical activity (SPA). Voluntary exercise can be defined as 
“locomotor activity that is not directly required for survival or homeostasis and not 
directly motivated by any external factor” (Garland et al., 2011). Volitional exercise can 
include sports, working out at a gym, and other related human activities, and possibly 
wheel running in rodents, although this is somewhat controversial (Garland et al., 2011). 
Spontaneous physical activity comprises activities related to daily life and survival. 
Obligatory activities encompass the acquisition of food, shelter and mates, as well as 
avoidance of predators and competing with rivals (Garland et al., 2011). This category 
may also include non-specific ambulatory behavior, grooming, rearing, fidgeting, 
maintaining posture, spontaneous muscle contraction, and other related behaviors. 
Spontaneous physical activity results in nonexercise activity thermogenesis (NEAT), 
which is the expenditure of energy. There is some overlap between the types of activity 
and the definitions vary within the field, making it difficult to compare studies (Garland 
et al., 2011).   
There is a balance between daily energy intake and daily energy expenditure and 
if that balance is tipped one way or another it results in underweight or overweight 
individuals.  Voluntary exercise and SPA can both play important roles in maintaining 
that balance (Garland et al., 2011).  Humans in developed countries generally do not 
engage in much voluntary exercise, but this could potentially be offset by an increase in 
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SPA, and therefore NEAT, if sedentary behaviors are reduced (Garland et al., 2011). 
However, many people do not need to perform spontaneous physical activities in their 
daily lives. Much time is now spent in front of a computer or television, or in a vehicle.  
Social and societal environments have significant influence on SPA, but there are also 
important biological components to consider. Studies have shown that SPA, and in turn 
NEAT, is affected by stimulation and lesioning of the brain (Garland et al., 2011; Kotz, 
2008). Dopaminergenic pathways have been associated with SPA, as well as many 
neuropeptides that may be involved in these pathways including NPY, AgRP, leptin and 
orexins (Garland et al., 2011).  
Many studies have shown that orexins, in particular, are central components in 
SPA and NEAT.  Two forms of this peptide, orexin A and B, are produced in the 
hypothalamus. There are also two receptors. Orexin A has a higher binding affinity for 
both receptors and is more studied than orexin B (Sakurai et al., 1998). SPA is increased 
in rats when orexin A in injected into specific areas of the brain, and this effect is 
reversed when an antagonist for orexin receptor 1 in injected prior to orexin A (Kotz et 
al., 2006). Obesity resistant rats display an increase in SPA behavior compared to 
wildtype rats and this is associated with reduced fat mass gain (Teske et al., 2012) and 
increased expression of orexin (Teske et al., 2006).  Despite decreased food consumption, 
orexin knockout mice become obese, which is likely due to a significant decrease in SPA 
(Hara et al., 2001). Narcolepsy in humans is associated with orexin deficiency as well as 
an increase in body weight (Dahmen et al., 2001; Kotagal et al., 2004), which may 
possibly be due to reduced SPA. 
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 Activity level in offspring has been shown to be altered by maternal diabetes. 
Children born to diabetic mothers have been found to have increased hyperactive 
behavior (Ornoy et al., 1998). A series of behavioral tests were given to children ages 5 
to 12 from mothers with well controlled diabetes and mothers without diabetes. Children 
of diabetic mothers had scores on the Pollack tapper test and the Conners abbreviated 
parent-teacher questionnaire that indicated an increase in hyperactivity (Ornoy et al., 
1998).  A rat model of type I diabetes was used to study the effect of maternal 
arachidonic acid supplementation on offspring behavioral outcomes. Female rats were 
injected with streptozotocin, which is selectively toxic to the insulin producing beta islet 
cells in the pancreas, to artificially induce diabetes, which was either well or poorly 
controlled (Zhao et al., 2009). These mice were mated and fed either a control diet or a 
diet supplemented with arachidonic acid (AA). They found that offspring from dams with 
poorly controlled diabetes and/or dams supplemented with AA had increased activity in 
an open field maze at 8 and 12 weeks of age (Zhao et al., 2011).  They also found that 
offspring from dams supplemented with AA, regardless of diabetic condition, performed 
better on a rotarod test, which tests coordinated motor skills (Zhao et al., 2011).   
Other rodent studies have also shown that activity can be affected by maternal 
nutrition.  In one study, mice dams were given a diet high in polyunsaturated fatty acids 
(PUFA), which can have negative effects in high amounts (Sultana et al., 2003), 
beginning 1 week before conception and ending after giving birth. They were placed on a 
regular chow diet throughout lactation. At 2, 3 and 12 months of age, offspring from 
dams on the high-PUFA diet were found to be more active in an open field maze 
(Raygada et al., 1998). Vickers and others (2000) found that adult offspring from 
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undernourished rat dams became obese, which was associated with increased food intake 
that preceded increased weight gain. They then looked at activity and observed decreased 
locomotor behavior in offspring from undernourished dams (Vickers et al., 2003), which 
could also contribute to the development of adulthood obesity. These studies show that 
maternal nutritional state can program offspring activity behavior, which, in turn, affects 
their risk of obesity. Since leptin has is associated with maternal obesity, nutrition and 
diabetes, as well as SPA, it is possible the maternal leptin levels may program offspring 
SPA in childhood and adulthood. 
Anxiety in offspring has also been shown to be affected by the in utero 
environment (Bilbo and Tsang, 2010; Rizzo et al., 1997a; Rizzo et al., 1997b; Walker, 
2010) and is associated with inactivity and obesity (Strine et al., 2008).  Children born to 
mothers with diabetes during pregnancy scored lower on a Sequential ability test, which 
shows sequential processing abilities as well as testing for disruptive anxiety (Rizzo et 
al., 1997a).  In another study by the same group, children from diabetic mothers were 
more likely to be obese and that obesity was associated with an increase in anxiety (Rizzo 
et al., 1997b). A study in rats looked at the effect of a maternal high-saturated fat diet or 
high-trans fat diet versus a low-fat control diet on learning, anxiety and neurological 
development in offspring. Male offspring of dams from both of the high fat diet groups 
had increased anxiety compared to the controls (Bilbo and Tsang, 2010).  Walker (2010) 
found that offspring from high-fat fed mothers had reduced stress response and that 
offspring chronically treated with leptin, for 10 days after birth, had a similar reduction in 
stress response.  This suggests that leptin could play a role in programming offspring 
anxiety.  
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1.4   Conclusions 
 
Leptin is an essential component of reproduction, although knowledge of its functions in 
this complex biological process is still incomplete. Further research is required to 
understand the role it plays in placental and fetal development, and its relationship to 
obstetric disorders that have short-term and/or long-term effects on the health of the 
mother and fetus. Understanding more about leptin and its functions could lead to 
therapies for human disorders, such as obesity and gestational diabetes, for example, 
leptin sensitization, to overcome leptin resistance. Leptin resistance is associated with 
both maternal obesity and gestational diabetes and may be involved in predisposing 
offspring to obesity.   
28 
 
CHAPER 2 
 
EFFECTS OF LEPTIN RECEPTOR ON PLACENTAL 
DEVELOPMENT AND FUNCTION 
 
2.1   Introduction 
 
Leptin is a multifunctional hormone produced in adipose tissue for which serum 
concentrations are in proportion to fat mass (Hickey et al., 1996). It is a major regulator 
of energy homeostasis (Kowalski et al., 2001), and is required for successful reproduction 
(Malik et al., 2001). Food restriction lowers leptin levels in pregnant mice (Schlitt and 
Schulz, 2011) and affects placental and fetal growth (Clarke et al., 1998; Schlitt and 
Schulz, 2011).  Leptin communicates nutritional and energy status of the body to the 
reproductive system, so it may also be partially responsible for the placental alterations 
caused by food restriction. We have recently shown that food restriction with leptin 
treatment alters the adaptive changes caused by the restriction (Schulz et al., 2012). 
Leptin in necessary for implantation (Malik et al., 2001) and stimulates trophoblast 
invasion, metalloproteinase activity, and blastocyst adhesion and outgrowth in vitro 
(Castellucci et al., 2000; Schulz and Widmaier, 2004; Yang et al., 2006).  It has also been 
found to affect angiogenesis (Sierra-Honigmann et al., 1998), and to  stimulate amino-
acid transport (Jansson et al., 2003) in cultured human placental cells. The placenta is 
essential to the health and survival of the fetus. It is the site for the exchange of nutrients, 
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gas and waste between the mother and fetus. From implantation to birth the placenta is 
developing to help regulate fetal growth and development and leptin plays a role in that 
process, but its precise functions are still unclear.  
The current study investigates the effect of leptin receptor on placental gene 
expression and morphology. To our knowledge, there have been no in vivo studies 
utilizing leptin receptor knockouts to look at placental morphology and global and 
specific gene expression. Studying the leptin receptor in vivo allows us to observe 
biologically relevant data on the entire placenta, not just one cell type that is artificially 
cultured. This novel in vivo study utilizes a leptin receptor null mouse model (Leprdb3j), 
which has a mutation in the gene encoding the leptin receptor that causes a 17bp deletion 
in exon 11. This 17bp deletion in exon 11 causes the protein to become truncated 11 
amino acids after the deletion, and thus prevents the production of any known isoforms 
(Lee et al., 1997).  In the homozygous state, Leprdb3j mice are diabetic and obese due to 
hyperphagia, decreased energy expenditure, and increased conversion of calories into fat. 
They are also infertile and cold intolerant (Kowalski et al., 2001). A model similar to 
Leprdb3j is the Leprdb mouse, which lacks only the long form of the leptin receptor.  In the 
heterozygous state, the Leprdb/+ mice have normal a phenotype, but when pregnant they 
can develop gestational diabetes, and hyperleptinemia (Yamashita et al., 2001), which 
likely affects fetal development.  Here, we mated reciprocal crosses of Lepr+/+ and 
Leprdb3j/+ mice to measure glucose tolerance, insulin and leptin. We found no difference 
in glucose tolerance or insulin levels between Lepr+/+ and Leprdb3j/+ dams, but Leprdb3j/+ 
dams do have hyperleptinemia. Therefore, in the current study, embryos were transferred 
from heterozygous Leprdb3j/+ x Leprdb3j/+ matings into wildtype recipients to examine the 
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effects of embryonic and placental leptin receptor deficiency while controlling for any 
maternal effects. We hypothesized that lack of leptin receptors in the conceptus will alter 
placental gene expression and morphology.  
 
2.2   Materials and Methods 
 
2.2.1   Animals 
All animal procedures were approved by the University of Missouri–Columbia 
institutional animal care and use committee and performed in accordance with the 
National Institutes of Health Guide for the Care and Use of Laboratory Animals. Two 
heterozygous Leprdb3j/+ male mice were obtained from Dr. Streamson Chua at the New 
York Obesity Nutrition Research Center (New York, New York). They were mated to 6 
C57Bl/6 wild-type females received from Jackson Laboratory (Bar Harbor, Maine) to 
establish the colony. Reciprocal crosses of Lepr+/+ and Leprdb3j/+ mice were made, and 
glucose tolerance tests were performed on pregnant wildtype and heterozygous females 
on day 18.5, and then they were sacrificed to collect blood for measurement of serum 
leptin and insulin. Leprdb3j/+ males and females were mated to produce embryos to 
transfer into in C57Bl/6 wildtype recipient females (Harlan, Indianapolis, IN). 
Vasectomized CD1 wildtype males (Harlan, Indianapolis, IN) were used to induce 
pseudopregnancy in wildtype recipients. All animals were group housed, or housed in 
pairs after surgery, in a 12/12 light/dark cycle at 68°F to 79°F with 30% to 70% 
humidity. 
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2.2.2   Genotyping 
Tail clips were taken from weanlings (three weeks old) or fetuses (d 18.5) for 
genotyping. The clips, approximately two mm in length, were placed in 200 μl of lysis 
buffer (50 mM KCl, 10 mM Tris-HCl (pH 8.3), two mM MgCl2, 0.1mg/ml gelatin, 
0.45% Nonidet p40, 0.45% Tween 20) containing 0.5 mg/ml proteinase K, incubated at 
55°C for three hours to overnight, then incubated at 95°C for 10 minutes to inactivate the 
proteinase K. PCR Master Mix (2x) (Fermentas.) Primers published by Lee et al. (1997), 
with 400ng of gDNA template, were used under the following conditions: 95°C for four 
minutes, 40 cycles of (95°C for 30 seconds, 57°C for 30 seconds, 72°C for 30 seconds).  
Products were visualized on a 2% agarose gel in a 5mM borax buffer (pH8.3) at 70 volts. 
The Lepr+/+ mice produce a band that is 180 base pairs long; the Leprdb3j/db3j band is 163 
base pairs and Leprdb3j/+ have both bands. 
2.2.3   Embryo Transfer 
Embryos, of all three genotypes (Leprdb3j/db3j, Leprdb3j/+, Lepr+/+), from Leprdb3j/+ x 
Leprdb3j/+ crosses were flushed from the uteri of donor females on gd3.5 and placed in 
warmed (37°C) CZBH (EmbryoMax CZB Medium with Phenol Red (Millipore) with 
22mM HEPES) (Life Technologies, place) until they were transferred. Isoflurane gas was 
used to anesthetize gd2.5 pseudopregnant recipient females. The recipient ovary was 
exteriorized through a small incision parallel to the spinal column just enough to have 
access to the uterotubal junction, and a Dieffenbach vessel clip was attached to the fat 
pad to hold the tissue in place. A Stripper pipette tip (Origio MidAtlantic Devices, Mount 
Laurel, New Jersey) was then inserted into the uterus via an incision in the oviduct, and 
the embryos were expelled into the lumen. The ovary and uterus were placed back into 
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the body cavity and the incision closed. For analgesia, 0.05 mg of Prevail (flunixin 
meglumine) (VetOne) was given via subcutaneous injection. Thirty-four transfer 
surgeries were performed with 13 successful pregnancies (38% success rate). Refer to 
Table 1 for the number of embryos transferred, number of fetuses and fetal genotypes. 
 
Table 1 Embryo Transfer Data 
 
 
2.2.4   Sample Collection 
At day 18.5 of gestation, pregnant females from reciprocal crosses were fasted for 
six hours and then given 1 mg/g body weight of glucose via intraperitoneal injection. 
Blood glucose levels were measured at 0, 15, 20, 30, 60, and 120 minutes following 
glucose administration using a OneTouch Ultra Glucose Meter and test strips (Life Scan, 
Inc.). Females were then euthanized via CO2 and cervical dislocation for sample 
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collection. Maternal blood was collected via cardiac puncture for serum, placed in 1.5 ml 
microcentrifuge tubes and centrifuged at 1xg for 12 minutes at 4°C.  Serum was siphoned 
off and placed in new tubes, then stored at -20°C until analysis.  
Pregnant recipients from the embryo transfers were also euthanized at day 18.5 of 
gestation. The uterus was removed, leaving some decidua, and each conceptus was 
separated after noting its location.  The placentas were carefully detached from the 
umbilical cords and uterus. Placental and fetal weights were recorded. Each placenta was 
cut in half. One half was fixed in 4% paraformaldehyde for morphological analysis. The 
other half was placed in TriReagent (Sigma, St. Louis, MO) and stored at -80°C until 
RNA isolation was performed. Fetal tails were placed in lysis buffer for genotyping, as 
described above. 
2.2.5    ELISAs 
A rat/mouse insulin ELISA (Millipore, St. Charles, MO) was used to determine 
maternal serum insulin concentrations in pregnant wildtype and Leprdb3j/+ females from 
reciprocal crosses. The manufacturer’s assay procedure was followed, with the primary 
antibody incubation period extended to overnight (intrassay variation: 5.9%). A mouse 
leptin ELISA kit (Millipore, St. Charles, MO) was used to determine maternal leptin 
concentrations according to manufacturer’s instructions, with the primary antibody 
incubation period extended to overnight (intrassay coefficient of variation: 9%).  
2.2.6  Microarray Analysis 
There were five litters that had at least one wildtype and one Leprdb3J/db3J placenta, 
and only these were used to control for any maternal effect. Two placentas, one of each 
genotype, from each of the five litters were used for microarray analysis. Placental 
samples stored in TriReagent (Sigma, St.Louis, MO) were thawed, then homogenized 
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and phases separated according to manufacturer’s instructions. The RNA was then 
purified by using the RNEasy Mini Kit (Qiagen, Valencia, CA) per manufacturer’s 
instructions. RNA was sent to GenUs Biosystems (Northbrook, IL) for microarray 
analysis. Mouse whole-genome arrays (design ID 026655; Agilent) containing >39,000 
probes were scanned on an Agilent G2565 Microarray Scanner. Data were analyzed with 
Agilent Feature Extraction and GeneSpring GX v7.3.1 software. Expression was 
considered to be different between wildtype and leptin receptor null placentas if 
expression was >150% or <66.7%, P<0.05.  Gene expression in both placentas from one 
dam was divergent from the  placentas from the other 4 dams. As this dam had been 
observed to be in labor at the time of collection, results from these placentas were 
excluded from all analyses. 
The functional annotation clustering feature of the DAVID Bioinformatics 
Resource (Dennis et al., 2003) was used to categorize genes to determine what biological 
pathways may be affected by altered gene expression. 
2.2.7   qRT-PCR 
Real-time RT-PCR analysis was used to validate selected array results, by using 
the same RNA samples analyzed by microarray. Reverse transcription was carried out 
with Superscript III (Invitrogen, Carlsbad, CA) with random hexamer primers via 
manufacturer instructions. Quantitative PCR on selected genes was performed with RT2 
SYBR Green ROX qPCR Mastermix (Qiagen, Valencia, CA) on an Applied Biosystems 
7500 real-time PCR system using validated primers from Integrated DNA Technologies 
(Coralville, IA). Primers for Pcdh12, Grb10, Gcm1, Cpt1b and Acacb were designed 
using Primer Express software (Applied Biosystems/Life Technologies), except 
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Esx1(Schaiff et al., 2007), Hprt (Pattyn et al., 2006), which have been previously 
published.  
2.2.8   Morphological Analysis 
Morphological analysis was conducted on placentas from litters containing at 
least one wildtype and one Leprdb3J/db3J placenta.  Fixed placental halves were embedded 
in paraffin with the cut-face down (RADIL, Columbia, MO). Three pairs of serial 5-µm 
sections were cut at 50-µm intervals from each placenta and were either stained with 
hematoxylin and eosin (H&E) (RADIL, Columbia, MO) or Periodic Acid-Schiff (PAS). 
Placentas stained with H&E were used for measuring total placental, junctional zone and 
labyrinth zone areas. Images of overlapping sections of each placenta were taken with a 
4X objective lens on an Olympus IX81 microscope, then arranged and aligned into a 
single image of the entire placental cross section.  
Placentas from recipients carrying any combination of embryonic genotypes were 
included in the analyses of the placental areas, because statistical analysis of placentas 
coming only from dams carrying both genotypes indicated that the dam did not have an 
effect. Placental sections stained with PAS were used to identify glycogen cell (GC) areas 
in the junctional zone, and maternal and fetal blood space areas in the labyrinth zone. 
Three different placental sections from each mother were used to determine the average 
combined GC areas. Overlapping pictures of the junctional zone were taken with a 20X 
objective lens, then arranged and merged by using Adobe ® Photoshop ® CS4 
Photomerge.  
To measure maternal and fetal blood space areas, five sections of the labyrinth 
zone from one PAS stained placenta from each mother were photographed with a 40X 
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objective lens.  Fetal blood spaces were identified by the staining of the basement 
membrane which outlines them and the presence of nucleated red blood cells. Areas were 
measured by using the freehand selection tool and area calculation feature of ImageJ 
software (NIH). 
2.2.9   Periodic Acid-Schiff Staining 
Unstained placental sections mounted on slides were deparaffinized and hydrated 
using xylene substitute followed by decreasing ethanol washes and ending in deionized 
water. The Periodic Acid-Schiff (PAS) Staining System (Sigma-Aldrich) was used to 
stain placental sections per manufacturer’s instructions. Tissues were counterstained with 
hematoxylin, then dehydrated. Permount (Fisher Scientific) and coverslips were then 
applied to mount and preserve the tissue staining. 
2.2.10   Statistics 
Paired t-test was used to analyze the microarray data. All other comparisons were 
analyzed by the Student’s t-test. 
 
2.3   Results 
 
2.3.1   Pregnant Leprdb3j/+Dams 
Pregnant heterozygous Leprdb3j/+ females had significantly higher leptin than 
Lepr+/+ controls at day 18.5, but their insulin levels and response to glucose were not 
significantly different (Figure 2). 
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Figure 2.  Leprdb3j/+ Maternal Leptin, Insulin and Glucose Tolerance. Day 18.5 
maternal serum (A) leptin and (B) insulin concentrations. (C) Maternal glucose tolerance 
test. (wt, n=3;   3j/+, n=4) (t-test, * p<0.05) +/+, Lepr+/+; 3j/+, Leprdb3j/+ 
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2.3.2   Microarray Analysis 
 
Figure 3.   Leprdb3j/+ vs. Lepr+/+ Microarray Cluster Diagram. Differentially 
expressed genes (>1.5 fold, Paired T-test p-value < 0.05, 413 probes) in Leprdb3j/db3j vs. 
Lepr +/+ are displayed as normalized to the 75th percentile intensity of each array and 
further normalized to the median gene expression across eight samples.  Red=High 
expression, Yellow=Medium expression, Blue=Low expression   
 
Gene expression in wildtype and leptin receptor null placentas from the embryo 
transfer surgeries were analyzed via whole-genome microarray (GEO accession no. 
GSE38095). There were 413 differentially expressed genes detected by microarray 
analysis and the four placentas in each genotype clustered tightly (Figure 3). DAVID 
functional annotation clustering was used to categorize genes to determine which 
biological pathways were affected by ablation of placental leptin receptor (Table 3). The 
most overrepresented functional clusters (one and two) identified by the DAVID analysis 
of the 325 upregulated genes in the lepr-null placentas were related to transport, such as 
hydrogen and cation symporter activity, and carboxylic acid, organic acid, amine and 
amino acid transport. There were seven solute carrier (Slc) family genes listed in those 
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two clusters of the 14 genes that were altered on the microarray. Twelve of the Slc genes 
were upregulated in the lepr-null placentas (Table 3).  The 3rd cluster in the list of 
upregulated genes is associated with membrane coat, which is also involved in transport 
activity and transport of cations, hydrogen, sugar and carbohydrates (Table 2). There 
were 5 other clusters of genes that had significant enrichment scores (See Table 2). There 
were only 2 clusters with significant enrichment scores in the DAVID analysis using the 
list of 88 genes down-regulated in the lepr-null placentas (Table 2). The first set of genes 
was categorized into signal, secreted, extracellular or disulfide bond. The second cluster 
contains genes associated with the enzymes and enzyme activity involving the 
breakdown of proteins. 
 
Table 2.  TheDAVID Functional Annotation Cluster Analysis of Differincially 
Expresssed Genes in Leprdb3j/db3j Placentas 
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Table 3. Solute Carrier Fold Changes from Leprdb3j/+ vs. Lepr+/+ Microarray 
 
 
Several of the genes from the microarray were of interest due to their involvement 
in placental invasion or morphological development.  Stathmin 1 (Stmn1), Storkhead box 
1 (Stox1), Prolactin family 3, subfamily d, member 1 (Prl3d1; formerly placental 
lactogen 1 (Pl-1) ) and Autophagy related 4C, cysteine peptidase (Atg4c) have all been 
associated with placental invasion and were down regulated in the Lepr-null placentas 
(Table 4). Histone deacetylace 1 (Hdac1) was down regulated in the lepr-null placentas, 
while DNA methyltransferase 3 cofactor (Dnmt3l) was upregulated (Table 4), but both 
are involved in placental morphological development. Scl6a4, which transports serotonin 
across the placenta, and Scl22a3, which is involved in serotonin degradation, were down 
regulated and up regulated respectively (Table 4).  
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Table 4. Selected Genes from Leprdb3j/+ vs. Lepr+/+ Microarray and qPCR Validation 
 
 
Genes of interest from the microarray were selected for verification by 
quantitative Polymerase Chain Reaction (qPCR). Glial cells missing 1 (Gcm1), Acetyl-
coenzyme A carboxylase beta (Acacb), Carnitine palmitoyltransferase 1b (Cpt1b), 
Growth factor receptor bound substrate 10 (Grb10) were all up-regulated in lepr-null 
placentas on the microarray (Table 4). Protocahherin-12 (Pcdh12) and Esx Homeobox 1 
(Esx1), markers of the glycogen cell and syncytiotrophoblast lineages, respectively, 
were unchanged in the microarray, and PCR (Table 4). Gcm1, Grb10 and Cpt1b showed 
fold-differences in the qPCR analysis between Lepr null and wildtype placentas similar 
to those observed by microarray (Table 4); however there were no significant 
differences.  
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2.3.3   Placental and Fetal Weights and Morphology 
Litter sizes of one to seven, averaging at four, were observed following 13 
successful embryo transfers (Table 1).  After exclusion of one dam that was in labor at 
the time of collection, data were collected from 10 litters had at least one wildtype or 
Leprdb3J/db3J conceptus. There were no statistically significant differences in fetal or 
placental weights, but the latter trended lower in leptin receptor nulls (p = 0.28 and 0.051, 
respectively) (Figure 4). The ratio of fetal to placental weight was not different either 
(Figure 4).  
We assessed placental development by examining several morphological 
parameters:junctional zone, labyrinth zone and total placental surface areas, which were 
traced by hand  and measured in ImageJ. The junctional zone/labyrinth zone ratio was 
then calculated. The  glycogen cell size, and maternal and fetal blood space surface areas, 
were also traced by hand and calculated in ImageJ (Figure 4). There were no significant 
differences, though the junctional zone/labyrinth zone ratio trended lower in the lepr-null 
placentas (p = 0.16). 
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Figure 4. Leprdb3j/+ Placental Morphology. (A) Average fetal wet weights. (B) 
Averange placental wet weights. (C) Fetal/placental weight ratio (D) Total placental area 
(junctional zone plus labyrinth zone areas). (E) Cross-sectional area of the junctional 
zone and  (F) labyrinth zone. (G) Junctional Zone/Labyrinth zone ratio. (A-G: Lepr+/+ , 
n=10; Leprdb3j/db3j, n=9) (H) Glycogen cell areas (Lepr+/+ , n=6; Leprdb3j/db3j, n=6) (I) 
Maternal and (J) Fetal blood space areas. (K) Maternal/Fetal blood space area ratio. (I-K: 
Lepr+/+ , n=6; Leprdb3j/db3j, n=7) (t-test, ^p=0.051) +/+, Lepr+/+; db3j/db3j, Leprdb3j/db3j; BS, 
blood space; GC, glycogen cells F, fetal; JZ, junctional zone; LZ, labyrinth zone; M, 
maternal; P, placental 
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2.4   Discussion 
 
The microarray analysis showed that knocking the leptin receptor out in the 
placenta had a significant effect on gene expression. Although the microarray was not 
validated by qPCR, there are genes of interest that could be the focus of future 
investigations. The most overrepresented set of genes were solute carrier (Slc) family 
genes. This is important because the main function of the placenta is to transport 
nutrients, gas and waste between the mother and fetus, and these genes play a role in that 
function.  All but one of the genes in this functional cluster were upregulated in the lepr-
null placentas.  
Two Slc genes of particular interest are Slc6a4 and Slc22a3, which both transport 
serotonin, which has been suggested to play a role in placental development and function, 
as well as fetal development (Bonnin and Levitt, 2011; Viau et al., 2009). Both are 
important regulators of serotonin (Verhaagh et al., 2001; Viau et al., 2009).  Slc6a4 was 
down regulated in lepr-null placentas. Similarly, it has also been found to be reduced in 
placentas from women with gestational diabetes (Viau et al., 2009). This serotonin 
transporter is expressed in migrating cells of the rat ectoplacental cone (Hansson et al., 
1998) and high levels of serotonin reduce neuronal crest cell migration (Moiseiwitsch and 
Lauder, 1995). Preeclampsia, which occurs when placental invasion is inadequate, has 
also been associated with high levels of serotonin (Bottalico et al., 2004). This suggests 
that SLC6A4 could potentially play an important role in placenta invasion. Serotonin is 
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also a vasoconstrictor, which could affect maternal-fetal blood flow, so regulation of 
serotonin is essential for proper placental function (Bonnin et al., 2011).  
The SLC22A3 transporter also transports serotonin, but was upregulated in lepr-
null placentas. This transporter is co-localized with monoamine oxidase A, which 
degrades serotonin, in the labyrinth of the mouse placenta (Verhaagh et al., 2001). In the 
hippocampus of mice, SLC22A3 increases serotonin clearance (Baganz et al., 2008). This 
suggests that SLC22A3 plays a role in regulating serotonin levels in the placenta. 
Overall, serotonin may affect placental invasion and blood circulation, so its regulation is 
important for proper placental development and function.  
The current study shows that lack of leptin signaling results in a down-regulation 
of Slc6a4 (transports serotonin across the placenta) and up-regulation of Slc22a3, 
(involved in the degradation of serotonin) which would result in a decrease in serotonin 
crossing the placenta. Decreased levels of serotonin are associated with increased cell 
migration and increased placental invasion (Hansson et al., 1998; Moiseiwitsch and 
Lauder, 1995), therefore lack of leptin signaling could result in increased placental 
invasion or act as a compensatory mechanism to offset reduced invasion caused by other 
altered genes (discussed below). Physiological situations involving reduced leptin 
signaling also means that less serotonin could be transported to the fetus, resulting in 
altered neuronal development causing behavioral or mental disorders, such as depression 
or anxiety (Bonnin and Levitt, 2011). 
There were several other genes that were differentially expressed in leptin 
receptor null placentas on the microarray that were of interest, several of which are 
associated with placental invasion. One of those genes was Stmn1, which was down 
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regulated in the null placentas, remaining consistent with our previous in vitro study 
showing that Stmn1expression was stimulated by leptin in primary mouse trophoblast 
cells (Schulz et al., 2009). A study in Drosophila oocyte border cells found that STMN1 
was required for normal migration (Borghese et al., 2006).  Stathmin 1 has been found to 
be overexpressed human hepatocellular carcinoma (HCC) cells and was associated with 
the migration and invasion of the tumor cells. When Stmn1 expression was suppressed in 
HCC cells using siRNAs, invasion was inhibited (Hsieh et al., 2010). A study looking at 
gene expression in mouse embryos lacking Stmn1 found that about half of the genes with 
differential expression were involved in cell adhesion and motility (Ringhoff and 
Cassimeris, 2009). Another study found that inhibition of stathmin in first-trimester 
trophoblast prevents cell migration (Yoshie et al., 2008). It is clear from these studies that 
STMN1 plays an important role in cell motility, migration and invasion, which are 
important processes for proper placental development and function. Lack of leptin 
signaling in the lepr-null placentas in this study may reduce placental invasion due to 
reduced Stmn1 expression.  
Another gene that has been associated with placental invasion is Stox1, which was 
down regulated in leptin receptor null placentas. Insufficient trophoblast invasion results 
in reduced placental blood flow and leads to preeclampsia, which increases the risk for 
fetal growth restriction (Odegard et al., 2000). A study of families in the Netherlands 
with more two or more sisters who developed preeclampsia found that affected sisters 
had Stox1 loss of function mutations (van Dijk et al., 2005).  In contrast, overexpression 
STOX1 mice resulted in preeclampsia-like symptoms (Doridot et al., 2013).  Despite the 
conflicting results, this suggests that STOX1 plays a role in preeclampsia and possibly 
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placental invasion. If STOX1 dysfunction leads to preeclampsia, then lepr-null placentas 
may have reduced placental invasion due to reduced STOX1. On the other hand, if Stox1 
overexpression leads to reduced placental invasion, then reduced expression of Stox1 in 
lepr-null placentas, may be a compensatory mechanism. Because other altered genes may 
lead to reduced invasion, such as stmn1 down-regulation.  
Prl3d1, placental lactogen 1 (PL-1), was down regulated in the leptin receptor 
null placentas, and has also been associated with placental invasion. Human placental 
lactogen (hPL) has been found  to be increased in pregnant women with placenta previa 
and invasive placenta (Kawashima et al., 2014), and decreased in women with 
preeclampsia. (Mannik et al., 2012; Mannik et al., 2010). This shows that hPL is high 
when the placenta is overly invasive and low with inadequate invasion.  Placental 
lactogens in mice have luteotropic functions that help maintain pregnancy (Galosy and 
Talamantes, 1995) and lactogenic functions during the second half of pregnancy 
(Thordarson et al., 1986).  There are two placental lactogens in rodents PL-1 and PL-2. 
Trophoblast cells first produce PL-1, then produce PL-2 during the second half of 
pregnancy (Soares et al., 2007). The role murine PLs have on the placenta is unclear 
because of redundancies, but pregnant females lacking one copy of the receptor have 
reduced glucose tolerance and decreased β-islet mass growth, demonstrating the 
importance for PL in regulating maternal glucose homeostasis (Huang et al., 2009). 
Similarly, human PL was found to promote maternal β-islet growth (Brelje et al., 1993). 
The down-regulation of Prl3dl in lepr-null placentas may reduce invasion and possibly 
affect blood flow.  It may also reduce maternal β-islet mass growth and glucose tolerance. 
High circulating leptin levels and leptin resistance is associated with pregnancies 
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complicated by diabetes (Lewandowski et al., 1999). Therefore, lack of placental leptin 
signaling resulting in the reduction of PL may increase the risk of developing gestational 
diabetes. 
Atg4c may also be involved in invasion, and it was down regulated in leptin 
receptor null placentas. This autophagy gene is involved in degrading and recycling 
intracellular proteins and organelles (Kusama et al., 2009). Autophagy has been shown to 
affect trophoblast invasion, but there are conflicting results as to whether it promotes 
(Nakashima et al., 2013) or inhibits (Choi et al., 2012) invasion. On the other hand, 
another study found no difference in invasion in JEG-3 trophoblast cells when autophagy 
was disrupted (Hung et al., 2013). Further studies are warrented to determine the role of 
autophagy in trophoblast invasion.  Autophagy is stimulated when glucose and oxygen 
levels are low, which may protect trophoblast cells  from apoptosis (Hung et al., 2013). 
Atg4c null mice develop normally, are fertile and have a normal lifespan; this is likely 
due to the many autophagic redundancies, although when under starvation conditions, 
these mice have a reduced autophagic response (Marino et al., 2007). Reduced invasion 
could result in reduced glucose and oxygen supply to the placenta and cause an increase 
in autophagy. However, in lepr-null placentas with reduced Atg4c expression, the 
autophagic response may be reduced, possibly resulting in an increase in trophoblast cell 
death.  
Two other genes are of interest due to their involvement in placental 
morphological development. Hdac1 and Dnmt3l both play an important role in regulating 
gene expression. Hdac1, was down regulated in leptin receptor null placentas, and is a 
negative regulator of histone acetylation (Kidder and Palmer, 2012). In embryonic and 
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trophoblast stem cells, HDAC1 is located near active genes, such as those involved in 
regulating self-renewal (Kidder and Palmer, 2012). However, HDAC1 has also been 
found to deactivate genes, such as Gcm1, which promotes fusion of syncyitiotrophoblast 
cells in the labyrinth (Chuang et al., 2006). Dnmt3l was upregulated in null placentas. 
The DNMT3L protein does not have DNA methylase activity, but acting as a cofactor to 
functioning DNA methyltransferases is necessary for maternal imprinting in the embryo 
and placenta (Arima et al., 2006). Mouse conceptuses lacking Dnmt3l have abnormal 
development of the labyrinth and spongiotrophoblast layers, and increased number of 
giant cells (Arima et al., 2006). Dnmt3l is overexpressed in carcinoma cells, which, in 
HeLa carcinoma cells, results in increased cell proliferation and anchorage-independent 
growth, altered morphology and changes in global gene expression (Gokul et al., 2009). 
HDAC1 and DNMT3L have significant involvement in the regulation of genes related to 
placental morphogenesis. Reduced Hdac1 in placentas lacking the leptin receptor may 
have a reduced population of trophoblast stem cells, due the reduced activity of genes 
related to self-renewal.  Due to the fact that HDAC1 deactivates Gcm1 expression, down-
regulation of Hdac1 in lepr-null placentas may be associated with the increased 
expression of Gcm1 in the microarray results, although this was not validated in the 
qPCR results. The up-regulation of Dnmt3l in lepr-null placentas could have stimulated 
cell proliferation and placental growth, both of which could be mechanisms 
compensating for the dysregulation of others genes that reduce placental invasion and 
growth due to lack of leptin signaling. 
Taken together, leptin signaling in the placenta likely plays an important role in 
trophoblast invasion, because when it is disrupted, many factors that may stimulate 
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invasion are down-regulated. This is consistent with the finding that leptin stimulates mouse 
trophoblast invasion in vitro. However, there may be mechanisms that help compensate for 
this. We did not see any morphological differences that would indicate insufficient 
placental invasion, such as increased placental size, specifically in the labyrinth, which 
would be an attempt to compensate for lack of nutrients. Reduced depth of the decidua is 
an indicator of reduced invasion; however we did not measure this. The microarray 
clearly shows that gene expression in lepr-null placentas is altered and Hdac1 and 
Dmnt3l may be important factors affecting expression of placental genes, some of which 
may act as compensatory mechanisms.  
Despite the considerable change in gene expression in the lepr-null placentas, 
there were no significant morphological alterations. Lepr-null placentas were numerically 
lighter than wildtype placentas, which may indicate a change that is too subtle for crude 
wet weight comparison to detect. We found no significant differences in total placental, 
junctional zone or labyrinth zone areas. Our group has previously reported a reduction in 
placental and junctional zone areas at day 11.5 in food restricted mice, which have 
decreased leptin levels (Schulz et al., 2012). Fetal to placental weight ratio, a measure of 
placental efficiency, was also not different.  
We looked at glycogen cell size in the junctional zone and found no differences. 
In our previous study, we observed a possible reduction in the number of glycogen 
vacuoles in day 11.5 placentas from food restricted and food restricted with leptin 
treatment (Schulz et al., 2012), which is consistent with the current study in that leptin 
does not seem to affect glycogen cells.  
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There were no differences found in the labyrinth blood space areas in the lepr-null 
placentas compared to controls. We have previously shown decreased fetal blood space 
areas in day 11.5 placentas from food restricted mothers versus food restricted mothers 
with leptin treatment (Schulz et al., 2012). Leptin has been shown to affect angiogenesis 
by stimulating it (Sierra-Honigmann et al., 1998) and blocking vascular endothelial 
growth factor (VEGF) secretions (Islami et al., 2003). VEGF expression was not found to 
be different in the microarray results.  Four genes that may play roles in angiogenesis 
were upregulated in the lepr-null placentas (Meox2, Prcp, Angptl3, C1qtnf3 (Akiyama et 
al., 2007)), which may indicate a compensatory mechanism was activated. We previously 
showed that C1qtnf6, which is involved in tumor angiogenesis (Takeuchi et al., 2011), 
was decreased in placentas from food restricted mothers and not in food restricted with 
leptin treatment (Schulz et al., 2012), indicating that leptin may stimulate angiogenesis 
through this pathway. On the other hand, leptin may interact with other physiological 
factors (like insulin, or specific nutrients) such that it has a different effect in well-
nourished and food restricted animals. In the current study C1qtnf3, which is also an 
angiogenic factor, was upregulated, not down regulated, in the lepr-null placentas which 
seems to contradict the results from our previous study. One study in humans showed that 
reduced leptin in fetal blood was associated with impaired vascularization (Huppertz et 
al., 2007). In contrast, a study in women with type 1 diabetes reported increased fetal 
leptin concentrations had little effect on placental vascularization (Nelson et al., 2009). A 
study in sheep also showed that leptin was not correlated with placental growth (Forhead 
et al., 2008).  Taken together, these studies reveal the complex nature of leptin and 
placental angiogenesis and the need for further research.  
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 2.5   Conclusion 
 
Even though there were no morphological alterations detected in the lepr-null 
placentas, there is clearly an altered gene expression profile, which indicates a possible 
change in placental function, possibly involving nutrient transport. Compensatory 
mechanisms may have been activated due to the lack of leptin receptors, which resulted 
in normal fetal and placental growth. Further investigation of placental function in lepr-
null conceptuses is needed.   
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CHAPER 3 
 
HYPERLEPTINEMIA DURING PREGNANCY INCREASES 
OFFSPRING ACTIVITY AND PROTECTS OFFSPRING 
FROM WEIGHT GAIN DURING ADULTHOOD 
 
3.1   Introduction 
 
Obesity rates have increased over the past few decades, along with associated 
health problems such as cardiac disease and diabetes. The CDC reported that in 2009-
2010, 35% of adults and 17% of children in the U.S. were obese (Ishimori et al., 2003). 
The ‘obesogenic’ environment in which many people live promotes poor nutrition and 
sedentary lifestyles and is a major contributor to the obesity problem. On the other hand, 
some people are more likely than others to become obese regardless of lifestyle. The 
Developmental Origins of Health and Disease hypothesis states that the in utero 
environment can have lifelong effects on the fetus (Barker et al., 1989). For example, 
children born to mothers who are obese or have Gestational Diabetes Mellitus (GDM) 
have a higher risk of becoming obese (Dabelea et al., 2000a; Drake and Reynolds, 2010). 
Mothers suffering from obesity and/or GDM also have high levels of the hormone leptin 
(Kautzky-Willer et al., 2001; Matsumoto et al., 2003). This is a multifunctional peptide 
that is involved in energy homeostasis (Kowalski et al., 2001), immunity (Bernotiene et 
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al., 2006),  reproduction (Malik et al., 2001; Yang et al., 2006), and brain development 
(Ahima and Osei, 2004). We have previously demonstrated that high maternal leptin in 
combination with maternal nutrient restriction, results in greater obesity and insulin 
resistance in female offspring given a high fat diet (Pennington et al., 2012). As leptin is 
high in both obese and GDM mothers, we hypothesize that it may be involved in 
predisposing their offspring to obesity.  
The in utero environment may lead to altered behaviors that increase offspring 
risk of obesity. Human studies suggest that children’s behavioral activity (Ornoy et al., 
1998), motor coordination (Ornoy et al., 1998; Petersen et al., 1988), and anxiety (Rizzo 
et al., 1997a) are affected by maternal obesity and/or GDM. Maternal diet during 
pregnancy is likely to impact human offspring feeding behavior (Brion et al., 2010). 
Altered feeding behavior (i.e. increased preference for fatty foods) (Brion et al., 2010) 
and increased anxiety (Rizzo et al., 1997a) could lead to increased risk for obesity and 
associated diseases in adulthood. Other behavioral changes could have a negative impact 
on the lives of those children, such as increased hyperactivity (Ornoy et al., 1998; Rizzo 
et al., 1997a), and decreased fine and gross motor coordination (Ornoy et al., 1998; 
Petersen et al., 1988), which could last into adulthood.   
The cause of these behavioral changes is still unknown. Rodent studies have 
shown that maternal nutrition and/or obesity during gestation affects offspring behavioral 
activity (Raygada et al., 1998; Vickers et al., 2003; Zhao et al., 2011), motor coordination 
(Zhao et al., 2011), anxiety (Bilbo and Tsang, 2010; Walker, 2010), and feeding behavior 
(Kirk et al., 2009; Ong and Muhlhausler, 2011; Vickers et al., 2003; Vucetic et al., 2010; 
Walker et al., 2008). It is difficult to compare the rodent studies and determine a cause 
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for the behavioral changes, due to the wide variety of experimental designs and methods. 
However, altered maternal nutrition and obesity during pregnancy are associated with 
altered leptin levels and leptin resistance, which could play a role in programming 
offspring behavior. 
The current study sought to determine whether hyperleptinemia during pregnancy 
alters offspring behavior in a way that increases their risk of weight gain. Two models of 
maternal hyperleptinemia were used. The first used the leptin receptor mutant mouse 
(Leprdb), which lacks the long form of the leptin receptor (McMinn, 2003). Females 
heterozygous for this mutation (Leprdb/+) have a normal phenotype until they become 
pregnant, and then they develop hyperleptinemia (Ishizuka et al., 1999). Under some 
conditions they develop gestational diabetes (Satoh et al., 2003; Yamashita et al., 2001), 
but that was not the case in this study. The second model used mini-osmotic pumps 
containing leptin implanted subcutaneously into female wildtype mice.  
After weaning, behavioral tests were begun on male and female wildtype 
offspring from the four maternal treatment groups. They were tested at three ages: 
juveniles from 4 to 6 weeks, young adults from 11 to 13 weeks, and adults from 19 to 21 
weeks. Five behaviors were evaluated: food consumption, food preference, locomotor 
activity, motor skills and anxiety-related behaviors. At 23 weeks some of the offspring 
were put on a high fat diet to identify potential interactions between exposure to an 
obesogenic environment and maternal hyperleptinemia. Three behaviors were then 
reevaluated at 27 to 28 weeks: food consumption, locomotor activity and anxiety-related 
behaviors.  Our hypothesis was that maternal hyperleptinemia would alter offspring 
behavior in a way that would promote obesity: increase food consumption and preference 
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for palatable food, decrease locomotor activity and motor coordination, and increase 
anxiety.  
 
3.2   Materials and Methods 
 
3.2.1   Animals 
 
All animal procedures were approved by the University of Missouri–Columbia 
Institutional Animal Care and Use Committee and performed in accordance with the 
National Institutes of Health Guide for the Care and Use of Laboratory Animals. Animals 
were housed in a 12/12 light/dark cycle at 68°F to 79°F with 30% to70% humidity. 
 
3.2.2   Experimental Design 
  
Two mouse models of maternal hyperleptinemia, each with its own control were 
used in this study. Evaluation of maternal glucose, insulin and leptin was conducted at 
gestational day 16.5 (d16.5). Male and female wildtype offspring from the four maternal 
treatment groups were subject to multiple behavioral tests at three ages. At 23 weeks of 
age some animals were placed on a high fat diet, while the others remained on a control 
diet, and several behaviors were reevaluated (Figure 5). 
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Figure 5. Maternal Hyperleptinemia Experimental Design Schematic. A: Experimental 
timeline: Mice were mated at the same time, 3 to 4 days after saline/leptin pump implantation. At 
day 16.5 postcopulation, all dams were fasted for 4 hours and blood was collected to measure 
glucose (Glu), insulin (Ins) and leptin (Lep). Wildtype offspring were tested for food 
consumption, food preference, activity, coordinated motor skills, and anxiety- like behaviors at 
three ages. Cohort 2 (see panel B) was place on a high fat diet, while cohort 1 remain on a control 
diet, food consumption, activity and anxiety-like behaviors were retested at 27 to 28 weeks of 
age. At 31 weeks of age hypothalami were collected. B: Experimental animal groupings and 
sample sizes: The experiment was conducted twice resulting in two cohorts. After offspring were 
weaned and genotyped, one male and one female offspring (if available) from each dam were 
randomly placed into a group testing feeding behaviors or in a groups testing activity, coordinated 
motor skills, and anxiety- like behaviors. All n’s reflect the number of dams represented. *, 2 
male offspring from cohort 2 were moved to cohort 1 due to small sample size. 
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3.2.3   Leprdb/+Model of Pregnancy Hyperleptinemia 
Four heterozygous Leprdb/+ male mice (Strain: B6.BKS(D)-Leprdb/J; stock 
number: 000697) obtained from Jackson Laboratory (Bar Harbor, Maine) were mated to 
eight C57Bl/6 wildtype females from our colony to establish the Leprdb colony. Tail clips 
were taken from weanlings (3 weeks old) for gDNA for genotyping according to the 
method published by Yamashita et al. (2001) with minor modifications. The clips, 
approximately 2mm in length, were incubated at 55°C for 3-18h in lysis buffer [50 mM 
KCl, 10 mM Tris-HCl (pH 8.3), 2 mM MgCl2, 0.1mg/ml gelatin, 0.45% Nonidet p40, 
0.45% Tween 20], then incubated at 95°C for 10 min.  Eight hundred nanograms of 
gDNA was amplified by PCR as described (Yamashita et al., 2001).  The PCR products 
were cut with AccI, then resolved on a 3.5% agarose gel and visualized with SYBR 
Green (Lonza, Rockland, ME).  
3.2.3.1   Glucose tolerance in Pregnant Leprdb/+ Mice. A glucose tolerance test 
was performed on pregnant Leprdb/+ mice prior to the developmental programming study 
to determine whether they develop diabetes during pregnancy. Reciprocal crosses were 
made between wildtype C57Bl/6 control females (WT n = 7) with Leprdb/+ males and 
congenic Leprdb/+ (DB/+ n = 9) females with wildtype males and they were maintained on 
TestDiet ® (St. Louis, MO) AIN-93g (7% fat). At day 18.5 of gestation, they were fasted 
for 6 hours, then given 2 mg/g body weight of glucose via intraperitoneal injection. Blood 
glucose levels were measured at 0, 15, 20, 30, 60, and 120 minutes following the glucose 
administration. At 0 and 30 minutes an additional 100 µl of blood was collected from the 
tail vein for measurement of serum insulin, and a terminal blood sample was collected via 
cardiac puncture at 120 min for measurement of serum leptin.  
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3.2.2.2   Developmental Programming by Exposure to Leprdb/+.  In cohort 1, 13 
Leprdb/+ females (DB/+) were mated with wildtype males and 13 of their wildtype sisters 
(WT) were mated with Leprdb/+ males for 4 days, resulting in three and seven litters 
respectively. In cohort 2, 24 Leprdb/+ females were mated with wildtype males and 12 
wildtype female siblings were mated with Leprdb/+ males, resulting in seven and six litters 
respectively (Figure 5).  These reciprocal crosses were performed to control for any 
potential littermate effects of fetal genotype.  The DB/+ females had a lower pregnancy 
rate then WT females, and an even lower survival of  pups, as some of the pups were still 
born or died soon after birth. (Table 5). At d 16.5, pregnant females were fasted for 4 
hours, and then blood was collected from the tail vein for measurement of fasting 
glucose, insulin and leptin (Figure 5). Wildtype offspring of each maternal genotype 
were randomized to behavioral studies as detailed below. Because there were only three 
male offspring from DB/+ dams in cohort one, two male offspring in the feeding 
behavior arm of cohort two, which had seven male offspring from the DB/+ dams, 
remained on a control diet instead of being placed on a high fat diet. They are represented 
as being part of cohort one in Figure 5. 
Table 5. Pregnancy Rates 
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3.2.3   Leptin Infusion Model of Pregnancy Hyperleptinemia 
Wildtype C57Bl/6 females obtained from our colony or received from Harlan 
(Indianapolis, IN) were infused with either leptin (LEP) or saline, as a control (SAL).  
Recombinant mouse Leptin (Sigma-Aldrich, L3772) was reconstituted in saline 
according to manufacturer’s guidelines.  Alzet Mini-Osmotic Pumps (Model 2004) 
(Durect Corporation, Cupertino, CA), releasing 0.25 µl/hr for 28 days, were filled with 
1.4 µg/µl leptin solution or saline following manufacturer’s instructions.  The pump was 
then inserted subcutaneously between the scapulae and parallel to the spine, with the flow 
moderator positioned away from the incision. Mice were allowed to recover for 3 to 4 
days before being placed with males for mating.  
3.2.3.1   Developmental Programming by Exposure to Leptin Infusion. Twelve 
wildtype female mice with pumps containing leptin, and 11 with pumps containing saline 
were mated to wildtype males in cohort 1, resulting in six and four pregnancies 
respectively.  Thirteen wildtype female mice with pumps containing leptin, and 14 with 
pumps containing saline were mated to wildtype males in cohort 2, resulting in 8 and 10 
pregnancies respectively.  In all matings, females were placed with males until a 
copulatory plug was detected or four to five days had elapsed, to insure pumps would last 
until parturition and pups were close in age. The SAL dams had somewhat lower 
pregnancy rates the LEP dams (Table 6).  At d 16.5, pregnant females were fasted for 
four hours, and then blood was collected from the tail vein for measurement of fasting 
glucose, insulin and leptin (Figure 5) and weights were recorded. Offspring were 
randomized to behavioral studies as detailed below. 
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3.2.4   Offspring Behavioral Tests 
Five behaviors (food consumption, food preference, coordinated motor skills, 
locomotor activity, and anxiety-related behaviors) were evaluated in the wildtype pups 
from the previously described matings at 4 to 6 weeks (prepubertal), 11 to 13 weeks 
(young postpubertal) and 19 to 21 weeks (old postpubertal) of age (Figure 5).  Up to one 
male and one female wildtype pup from each litter were randomized to feeding behavior 
studies, and up to one additional male and female wildtype pup were randomized to the 
motor skills, locomotor activity and anxiety-related behavior studies.  All offspring were 
weighed weekly from 4 to 31 weeks of age. Wildtype offspring were tested for food 
consumption, food preference, locomotor activity, coordinated motor skills, and anxiety- 
like behaviors at 3 ages. Cohort 2 (see panel B of Figure 5) was placed on a high fat diet, 
while cohort 1 remained on a control diet. Food consumption, locomotor activity and 
anxiety-like behaviors were retested at 27 to 28 weeks of age.  
Offspring in cohort 2 were placed on a high fat diet (DIO HFD D12450, Research 
Labs, New Brunswick, NJ) from weeks 23 to 31 while the first cohort were maintained 
on the regular chow diet.  Food consumption, locomotor activity and anxiety- related 
behaviors were reassessed in both cohorts at weeks 27 to 28 (Figure 5). Offspring being 
evaluated for feeding behaviors were housed individually so that food consumption of 
individuals could be measured. Those being evaluated of all other behaviors were group 
housed with three to five animals per cage. 
3.2.4.1   Feeding Behavior.  Male and female wildtype offspring were evaluated 
for total amount of food intake (ages 4,11,19 weeks) and food preference (ages 5,12,20 
weeks). For 7 days, consumption of a powdered standard chow diet (LabDiet 5008, 
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Purina, St. Louis, MO) mixed with 50% water was measured at 12-hour intervals by 
using specialized dishes that were previously constructed for this purpose (Schlitt and 
Schulz, 2012). Food preference was examined by introducing a high fat/high sugar chow 
diet (50% LabDiet 5008 Meal, 50% sweetened condensed milk (PD) (Schneider et al., 
2010) in addition to the standard chow diet (CD) in identical dishes and measuring the 
nightly consumption of each.  At age 28 weeks, both cohorts were assessed for food 
consumption over 5 days on their respective diets (cohort 1- standard chow; cohort 2 – 
high fat). 
3.2.4.2   Coordinated Motor Skills. At ages 4,11, and 19 weeks, coordinated 
motor skills (the ability to synchronize limb movements and maintain balance) were 
assessed by the University of Missouri Center for Translational Neuroscience using a 
rotarod apparatus (ENV-577M, Med Associates, Georgia, VT) as previously described 
(Sage et al., 2013).  The apparatus consisted of a horizontal rod 3.2 cm in diameter 
positioned 16.5 cm above its base (Figure 6).  Across three consecutive sessions (one 
session/day) mice were tested on the rotarod, which rotated at an increasing velocity for 
up to 5 min, and the dependent measure was latency to fall off the rotarod.  
  
Figure 6. Rotarod Apparatus 
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3.2.4.3   Locomotor Activity. Locomotor activity (movement from place to place) 
was assessed in the offspring at ages 5, 12, 20 and 27 weeks using automated open- field 
activity monitors (Med Associates, St. Albans VT) interfaced to a computer running Med 
Associates Activity Monitor (ver. 4.31) software, according to procedures used 
previously in the Center for Translational Neuroscience (Sage et al., 2013). The apparatus 
consisted of a transparent box surrounded by banks of infrared sensors that were 
connected to the computer (Figure 7).  Across 3 sessions (1 session/day) mice were 
placed in the center of the apparatus and allowed to move freely for 30 minutes.  The 
dependent measures were total distance traveled and distance traveled over each 5 minute 
increment. 
 
Figure 7. Open-field Activity Monitors 
3.2.4.5   Anxiety-related Behaviors. Anxiety-related behaviors (amount of 
exploring under adverse conditions) were measured at 6, 13 , 21 and 28 weeks of age via 
the elevated-zero maze (Sage et al., 2013; Wu et al., 2003) in the University of Missouri 
Center for Translational Neuroscience.  The zero/circular maze was divided into four 
quadrants of equal size; two quadrants had walls and the other two were open. It was 
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made of gray acrylic and the track was 10 cm wide, 105 cm in diameter and was elevated 
72 cm from the floor (Figure 8). Two meters above the apparatus was an incandescent 
lamp with no other light sources in the room.  White noise was played continuously. On a 
single session at each age mice were placed facing out of a closed maze area and the 
dependent measure was the ratio of time spent in the closed versus open areas of the 
maze. Each 5 minute session was video recorded, then two independent observers, 
blinded to offspring treatment group, recorded time spent in open and closed arms, the 
number of times the mice entered open or closed areas and the number of times they 
explored (looked over) the edge in the open areas. 
 
  Figure 8. Elevated Zero-Maze 
3.2.5   Blood and Serum Assays 
Blood glucose concentrations were measured using a OneTouch Ultra Glucose 
Meter and test strips (Life Scan, Inc.).A rat/mouse insulin ELISA (Millipore, St. Charles, 
MO) was used to determine serum insulin concentrations. The manufacturer’s assay 
procedure was followed, with the primary antibody incubation period extended to 
overnight (intrassay variation: 8.5%). A mouse leptin ELISA kit (Millipore, St. Charles, 
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MO) was used to determine leptin concentrations according to manufacturer’s 
instructions, with the primary antibody incubation period extended to overnight (intrassay 
variation d 18.5: 16.2%; d 16.5: 14.4%).  
3.2.6   Statistics 
Student’s t-test was conducted on the maternal glucose, insulin, and leptin measurements 
(DB vs. WT; LEP vs. SAL; WT vs. SAL; DB vs. LEP).  A repeated measures two-way analysis 
of variance (ANOVA) statistical test was used to analyze the maternal glucose tolerance test with 
fixed factors treatment group, time and treatment group x time as outlined by Littel et al. (1998). 
The offspring weights were  also analyzed by using a repeated measures two-way ANOVA with 
fixed factors maternal treatment, and offspring sex, age, and diet as outlined by Littel and others 
(1998). Offspring anxiety data at 28 weeks was analyzed using a three-way ANOVA with 
maternal treatment group, sex and diet (CD or HFD) as factors. All other behavioral data were 
analyzed by analyses of variance split-plot in space and time with fixed factors diet, sex, age, and 
days within age as outlined by Steel and others (1997) 
 
3.3   Results 
 
3.3.1   Maternal Glucose Tolerance, Insulin, Leptin and Weights 
At pregnancy d 18.5, DB/+ dams had significantly lower glucose levels during the 
glucose tolerance test at 15, 20, and 30 minutes after glucose administration (Figure 9A), 
indicating slightly better glucose tolerance than the control mothers. Maternal insulin 
levels at 0 and 30 min of the glucose tolerance test were not different (Figure 9B and C). 
Leptin levels, at 120 min, in the DB/+ dams was significantly higher than the WT dams 
(p = 0.05) (Figure 9D). 
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In the developmental programming studies, there was no significant difference in 
fasting glucose or fasting insulin concentrations among the four maternal treatment 
groups at pregnancy d16.5 (Figure 9E and F). Fasting serum leptin concentrations were 
significantly higher in DB/+ and LEP dams compared to their controls, WT and SAL, 
respectively (Figure 9G). The DB/+ dams also weighed significantly more than WT 
dams at day 16.5 (p < 0.01) (Table 6). There were no differences in litter size among the 
groups. 
 
Table 6. Average maternal weights and litter sizes of hyperleptinemic dams. DB/+ dams 
weight more than WT dams at gestational day 16.5 with no difference in litter sizes. 
Statistical variation represented as +SEM (**p < 0.01) 
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Figure 9. Hyperleptinemic Dams Glucose, Insulin and Leptin. Lacking of one copy of 
the leptin receptor (DB/+) results in maternal hyperleptinemia and does not cause glucose 
intolerance at 16.5 or 18.5 of gestation. A: A glucose tolerance test was performed after a 6 hour 
fast in wildtype (WT) and Leprdb/+ (DB/+) dams at gestational day 18.5 after giving a 2g/kg 
glucose bolus. Data are presented as averages ± SE and were analyzed by using two-way 
ANOVA. Blood was collected from the tail vain to measure insulin at the 0 (Panel B) and 30 
(Panel C) minute time points and leptin at the 120 (D) minute time point (n: WT=7; DB/+ = 9). 
The dams from the developmental programming study were fasted for 4 hours at gestational day 
16.5 and blood was collected from the tail vein to measure glucose (E), insulin (F) and leptin (G). 
Data for insulin, leptin and fasting glucose are presented as averages ± SE and were analyzed by 
using Student’s t-test (n: WT=13; DB/+ = 12; SAL=14; LEP=14) (*p<0.05; **p<0.01). 
3.3.2   Offspring Weights 
As they aged, offspring of dams with pregnancy hyperleptinemia gained less 
weight than their respective controls. Wildtype offspring from DB/+ dams weighed 
significantly less than offspring from WT dams at older ages (26, 27, 28, 30 and 31 
weeks), regardless of sex or diet (p < 0.05) (Figure 10A and C). Weights of offspring 
from LEP dams diverged from those of offspring from SAL dams at 25, 26, and 29 weeks 
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of age (p < 0.07), and were significantly lower at 31 weeks (p < 0.05) (Figure 10B and 
D). Male offspring weighed more than female offspring (p < 0.01) and cohort 2 animals, 
which were placed on the high fat diet at 23 weeks of age, weighed more that those on 
the control diet (p < 0.01), but neither sex nor diet influenced the effect of maternal 
hyperleptinemia. Overall, maternal hyperleptinemia reduced offspring weight gain. 
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Figure 10.Weights of Offspring from Hyperleptinemic Dams. Offspring from 
dams with hyperleptinemia (DB/+ and LEP) weighed less than their respective controls in 
adulthood regardless of sex or diet. Offspring from WT (solid line, closed circles) and 
DB/+ (dashed line, open circles) dams (males (A); females (C)), and SAL (solid line, 
closed squares) and LEP (dash line, open squares) (males (B); females (D)) were weighed 
weekly after weaning.  Male offspring (A and B) weighed more than female offspring (C 
and D) (p<0.01) and offspring on the high fat diet (HFD; grey) weighed more than those 
on a control diet (CD; black)   Data are presented as averages ± SE and were analyzed by 
using two-way ANOVA with offspring nested within dam. (n: Males: WT = 13; DB/+ = 
12; SAL = 14; LEP = 14; Females: WT = 11; DB/+ = 9; SAL = 14; LEP = 13) (^p < 
0.07; *p < 0.05) 
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3.3.3   Offspring Feeding Behavior 
3.3.3.1   Total Food Consumption. Female offspring from DB/+ dams consumed 
significantly more food daily at 19 weeks of age than those from WT dams (p < 0.05), 
with no difference at 4 or 11 weeks (p < 0.05) (Figure 11C). Females from LEP dams 
trended toward consuming more than females from SAL dams at 11 weeks (p < 0.06), but 
there were no statistically significant differences at any of the ages (Figure 11D). There 
were no differences in food consumption among male offspring of different maternal 
groups at any age (Figure 11A and B). Overall, females consumed more than males (p < 
0.01).  
There were no differences in food consumption among the groups at 27 weeks 
(Figure 11E to H). However, mice on the high fat diet consumed significantly less food 
than those on the control diet, regardless of maternal leptin status (p < 0.01).  
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Figure 11. Food Consumption of Offspring from Hyperleptinemic Dams. Food 
intake was higher in female offspring from DB/+ dams in adulthood.  Assessment at 5, 12 
and 20 weeks of age: A: male offspring from WT (black) and DB/+ (white) dams, B: 
male offspring from SAL (dark gray) and LEP (light gray) dams, C: female offspring 
from WT and DB/+ dams, D: female offspring from SAL and LEP dams. Male (E and 
F) and female offspring (G and H) food intake was reassessed at 27 weeks, some were 
on a high fat diet (HFD) and others on a control diet (CD). Offspring on a high fat diet 
consumed less regardless of maternal treatment (E inset). Data are presented as averages 
± SE and were analyzed by using analyses of variance split-plot in space and time with 
offspring nested within dam (n: Males: WT = 10; DB/+ = 10; SAL = 14; LEP = 12; 
Females: WT = 9; DB/+ = 6; SAL = 12; LEP = 13) (^p < 0.06; *p < 0.05). 
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3.3.3.2   Food Preference. Maternal hyperleptinemia in DB/+ mice resulted in 
female offspring consuming more total food in the food preference test at some ages, but 
reduced their preference for a highly palatable diet. During the food preference test, 
female offspring from DB/+ dams consumed the same amount of the highly palatable diet 
(PD) as female offspring from WT dams, but consumed more of the control diet (CD), 
and thus more food total, at 5 and 20 weeks of age (Figure 11C). At 12 weeks, female 
offspring of WT and DB/+ consumed the same amount of both the PD and CD. Overall, 
females offspring from DB/+ dams consumed more CD then those from WT dams 
regardless of age (p<0.05).  Females from LEP dams consumed more CD at 12 weeks 
than those from SAL dams (FIG 5D). At 5 and 20 weeks all females consumed more PD 
than CD, with no difference among the groups. Overall, female offspring from LEP dams 
consumed more CD than those from SAL dams regardless of age (p < 0.05).  Males 
consumed more PD than CD, but there were no differences among the groups at any age 
(Figure 12A and B).  
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Figure 12. Food Preference of Offspring from Hyperleptinemic Dams. Female 
offspring from DB/+ dams consumed more total food in the food preference test, and had 
a reduced preference of the palatable diet. Male (A&B) and female (C&D) offspring 
were given a control diet (CD) and a palatable diet (PD; sweetened condensed milk 
mixed with CD) ab libitum. Data are presented as averages and were analyzed by using 
analyses of variance split-plot in space and time with offspring nested within dam (n: 
Males: WT = 10; DB/+ = 10; SAL = 14; LEP = 12; Females: WT = 9; DB/+ = 6; SAL = 
12; LEP = 13) (**p < 0.01). 
 
3.2.4   Offspring Locomotor Activity in Open Field 
Hyperleptinemia in DB/+ dams increased the locomotor activity level of female 
offspring at all ages. There was also an increase in locomotor activity male offspring of 
db/+ dams, but only at 20 weeks (Figure 13A). Pairwise differences were statistically 
significant at 5 and 12 weeks on day 1 and 20 weeks on day 3 in the females (Figure 
13C).  While locomotor activity levels declined with age in the female offspring of WT 
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dams, they were more consistent over time in female offspring of DB/+ dams.  A 
significant effect on locomotor activity was not detected in female offspring from LEP 
dams compared to SAL, despite a numerical difference (Figure 12D) and decreasing p-
value overtime.  Similarly, in males, locomotor activity declined with age in offspring of 
WT dams, but at 20 weeks of age male offspring from DB/+ dams were significantly 
more active than offspring from WT dams on days 2 and 3 (Figure 13A). There was no 
difference in locomotor activity level between the male offspring from LEP and SAL 
dams at any age (Figure 13B).  There were no differences among the groups or across 
sexes in the time course of locomotor activity when evaluated in 5-mintue intervals 
across the 30-minute session (data not shown). All groups displayed higher levels of 
activity early in the session and lower levels later, indicating habituation to the open field. 
When the offspring locomotor activity was reevaluated (week 27) after cohort 2 
was placed on a high fat diet, male offspring had no significant differences among groups 
(Figure 13E and F). The female offspring from DB/+ dams that were on the high fat diet 
were significantly more active than offspring from WT dams on days 1 and 2, while those 
on the control diet were not different (Figure 13G).  There were no statistically 
significant differences between the female offspring from SAL and LEP dams (FIG 
10H). Again, there were no differences among the groups in the slopes over the 5 minute 
increments of the 30 minute sessions. 
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Figure 13. Locomotor Activity in an Open Field of Offspring from 
Hyperleptinemic Dams. Activity was increased in offspring from DB/+ dams. 
Assessment at 5, 12 and 20 weeks of age: A: male offspring from WT (black) and DB/+ 
(white) dams, B: male offspring from SAL (dark gray) and LEP (light gray) dams, C: 
female offspring from WT and DB/+ dams, D: female offspring from SAL and LEP 
dams. Male (E and F) and female offspring (G and H) food intake was reassessed at 27 
weeks, some were on a high fat diet (HFD) and others on a control diet (CD). Data are 
presented as averages and were analyzed by using analyses of variance split-plot in space 
and time with offspring nested within dam (n: Males: WT = 10; DB/+ = 10; SAL = 14; 
LEP = 13; Females: WT = 10; DB/+ = 9; SAL = 14; LEP = 13) (*p < 0.05; **p < 0.01). 
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3.3.5   Offspring Coordinated Motor Skills 
There were no impairments in rotarod activity that would reflect gross motor skill 
problems that would have affected their movement in the locomotor activity or anxiety-
related behavior analyses. There was no difference in learning over the 3 day time course 
at each age. There was a difference in performance in female offspring.  Female offspring 
from DB/+ dams remained on the rotarod significantly longer than their controls on day 
one at 11 weeks of age (Figure 14C). At the same age female offspring from LEP dams 
also had a significantly longer latency to fall than their controls (Figure 14D). There 
were no other differences among the females. There were no differences in coordinated 
motor skills among the males of any group (Figure 14A and B).  
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Figure 14. Coordinated Motor Skills of Offspring from Hyperleptinemic Dams. 
Coordinated motor skills were not impaired in any of the groups. Male (A and B) and 
female  (C and D) offspring were tested on the rotarod for up to 5 minutes on 3 
consecutive days at 4, 11 and 19 weeks of age.  Data are presented as averages and were 
analyzed by using analyses of variance split-plot in space and time with offspring nested 
within dam (n: Males: WT = 10; DB/+ = 10; SAL = 14; LEP = 13; Females: WT = 10; 
DB/+ = 9; SAL = 14; LEP = 13) (*p < 0.05) 
 
3.3.6   Offspring Anxiety-related Behaviors 
There were no significant differences in amount of time spent in the closed 
sections of the zero-maze between maternal hyperleptinemic groups and their controls at 
any age (Figure 15). Female offspring from DB/+ dams had a higher number of entries 
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into closed and open sections of the maze, compared to those from WT dams (Figure 
16B). There were no other differences among treatment groups at ages 6 to 21 weeks 
(Figure 16). When mice were reevaluated at 28 weeks of age, after cohort 2 was placed 
on the high fat diet, there were no differences in the amount of time spent in the closed 
areas of the maze between experimental groups and their controls. However, there were 
significantly more exploratory behaviors (entering either open or closed areas or looking 
over the edge) in male offspring of DB/+ dams than in offspring of WT dams on the 
control diet (Figure 16I). On the control diet, male offspring from LEP dams also took 
significantly more looks over the edge than male offspring of SAL dams (Figure 16K).  
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Figure 15. Anxiety-related Behaviors of Offspring from Hyperleptinemic Dams. 
Anxiety-like behaviors were not different among the treatment groups. The amount of 
time the offspring spent in closed areas of the zero-maze was assessed at weeks 5, 13 and 
21 (A-D) and reassessed at 28 weeks (E-H), with some on a high fat diet (HFD) and 
others on a control diet (CD). Males (A,B, E,F); Females (B,C,G,H). Data are presented 
as averages ± SE and were analyzed by using by using analyses of variance split-plot in 
space and time with offspring nested within dam (weeks 5-21) or three-way ANOVA (28 
weeks) (n: Males: WT = 10; DB/+ = 10; SAL = 14; LEP = 13; Females: WT = 10; DB/+ 
= 9; SAL = 14; LEP = 13). 
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Figure 16. Exploratory Behaviors of Offspring from Hyperleptinemic Dams 
Exploratory behavior was increased in male offspring from DB/+ dams. A to D: The 
number of entries into closed and open spaces on the zero maze and E to F: the number 
of times individual peered over the edge in open areas was assessed at 6, 13 and 21 
weeks. When cohort 2 was placed on a high fat diet (HFD) and cohort 1 remained on a 
control diet (CD) entries and edge explorations were reassessed at 28 weeks. Data are 
presented as averages ± SE and were analyzed by using by using analyses of variance 
split-plot in space and time with offspring nested within dam (n: Males: WT = 10; DB/+ 
= 10; SAL = 14; LEP = 13; Females: WT = 10; DB/+ = 9; SAL = 14; LEP = 13) (*p < 
0.05; **p < 0.01). 
81 
 
3.4   Discussion 
This study examined the role of high maternal leptin during pregnancy in 
developmental programming of offspring behaviors that regulate body size. 
Hyperleptinemia is associated with both maternal obesity and GDM (Kautzky-Willer et 
al., 2001; Matsumoto et al., 2003), both of which predispose offspring to obesity 
(Dabelea et al., 2000a; Tomita et al., 2003). We tested whether leptin was the mechanism 
behind this predisposition. Surprisingly, we showed that maternal hyperleptinemia, when 
isolated from maternal pathologies, was actually protective against excess weight gain, 
and that this results, at least in part, from greater spontaneous locomotor activity. 
However, locomotor activity was measured briefly in a novel environment in this study, 
which is not a highly accurate measure of long-term spontaneous physical activity or a 
measure of exercise. Therefore, further research is needed to understand the effect on 
maternal hyperleptinemia on offspring energy expenditure. 
Sex differences were seen in this study and have been seen in other 
developmental programming studies. One study found that male rat offspring born to 
dams who were 20% caloric restricted during the first half of pregnancy weighed more in 
adulthood (Palou et al., 2010). A study in rats found 50% food restriction during the first 
half of pregnancy resulted in both male and female offspring becoming obese, however it 
was more severe in the females (Desai et al., 2005). Male and female brains develop 
differently, particularly the hypothalamus, which is involved in both feeding and activity 
behaviors (Kotz et al., 2006; Sahu, 2004; Simerly, 2002). So, it is not unexpected that 
maternal hyperleptinemia affects male and female offspring behaviors differently. 
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There were also differences between the two models of hyperleptinemia. The 
offspring from LEP dams tended to have similar patterns to the offspring from DB/+ 
dams, but to a lesser degree. Although they are separate models and each have their own 
control, when looking at them as four groups, leptin levels in LEP dams was not 
significantly different from those of WT dams. This could be due to the fact that WT 
dams were mated to DB/+ males, resulting in a mix of WT and DB/+ conceptuses. It has 
been found that the offspring genotype can have an effect on maternal physiology (Petry 
et al., 2007).  
Another possible explanation for the differences between the two models of 
hyperleptinemia could be that the surgery could have affected the maternal physiology, 
since it is a stressful event, and stress in known to affect pregnancy (Barlow et al., 1975; 
Parker and Douglas, 2010; Pollock et al., 1984). However, the glucocorticoids, which 
increase during stress, stimulate leptin production (Udden et al., 2003), which doesn’t 
correspond with the lower leptin levels in both SAL and LEP dams.  
The lower levels of leptin in LEP dams may also be due to negative feedback. 
Leptin negatively regulates itself (Tessier et al., 2013), so exogenous administration of 
leptin could cause a reduction in the production of on endogenous leptin. This would 
result in lower levels of leptin overall than would otherwise be achieved by 
administration.   
3.4.1   The Leprdb/+ Model 
The Leprdb/+ mouse model used in this study has been reported to develop GDM 
(Ishizuka et al., 1999; Satoh et al., 2003; Yamashita et al., 2001), but others have failed to 
find evidence of glucose intolerance in these mice (Harrod et al., 2011). There may be 
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multiple factors that contribute to the onset of gestational diabetes mellitus in the 
heterozygous Leprdb/+ mice, including the amount of fat in their diet during pregnancy, 
number of previous pregnancies, paternal genotype, or the presence of the misty allele in 
the control group (Harrod et al., 2011; Ishizuka et al., 1999; Lambin et al., 2007; Saito et 
al., 2003; Satoh et al., 2003; Yamashita et al., 2001; Yamashita et al., 2003b). Our 
findings were consistent with those of Harrod and others, (Harrod et al., 2011) who found 
no difference in fasting glucose or glucose tolerance at gestational day 18 between 
Leprdb/+ and Lepr+/+ females on a 4 to 6% g/fat diet. Although it is still unclear under 
precisely which conditions Leprdb/+ mouse can be used as a model for GDM, under 
current conditions it is an ideal model for hyperleptinemia in the absence of 
complications of obesity, diabetes or altered diet. The DB/+ dams in this study were 
heavier than the WT dams and the LEP dams were numerically heavier, which shows that 
this animals are likely leptin resistant, because high leptin levels usually decrease food 
consumption and in turn, weight. This indicates that the protective effect leptin had on the 
offspring in this study was likely not due to reduced food consumption and maternal 
weight gain, although we did not measure maternal food consumption. 
3.4.2   Hyperleptinemia Models 
Few studies have looked at the developmental programming effects of any period 
of maternal hyperleptinemia without other confounding factors.  Those that have were 
generally consistent with our finding that maternal hyperleptinemia is protective. Leptin 
administration in rats from gestational day 14 through lactation protected offspring from 
diet induced obesity and diabetes symptoms (Stocker et al., 2004; Stocker et al., 2007).  
One study found that intake of a high fat diet was reduced in male offspring from leptin 
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treated dams. Also, both male and female offspring from leptin treated dams had 
increased energy expenditure when on a high fat diet (Stocker et al., 2007). There is some 
evidence that mouse dams heterozygous for a mutation at the agouti locus have high 
leptin without other metabolic alterations at a young age, and their offspring were also 
resistant to obesity (Makarova et al., 2013). These offspring had decreased weight gain 
after weaning,  were not hyperphagic, and gained less weight after fasting , though they 
were less responsive to exogenous leptin administration (Makarova et al., 2013).  The 
same study found that offspring from wildtype mouse dams injected with leptin at 
gestational day 17 had lower body weight, and male offspring had reduced food intake 
and diet induced obesity(Makarova et al., 2013). In contrast, a previous study from our 
lab showed that female offspring from mouse dams that were food-restricted and 
administered leptin during the first half of pregnancy became obese when given a high fat 
diet (Pennington et al., 2012). High leptin in a food-restricted animal would not occur 
naturally and the combination during pregnancy has negative effects on the offspring. In 
combination with the current study, there seems to be a growing body of evidence 
demonstrating that leptin protects offspring from becoming obese when they are exposed 
during pregnancy. 
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3.4.3   Programming of Offspring Feeding Behavior and Locomotor Activity  
Table 7. Behavioral Outcome Summary 
 
 
The protection from weight gain associated with maternal hyperleptinemia was 
not explained by decreased consumption of either standard or high fat chow (Table 7). 
There were no differences in feeding behavior among male offspring from control and 
hyperleptinemic mothers, and female offspring from dams with pregnancy 
hyperleptinemia actually consumed more food at some ages in both the food consumption 
and preference tests, despite reduced preference for the highly palatable diet (Table 7). 
Thus, it is possible that maternal hyperleptinemia contributes to the higher food 
consumption that has been observed in offspring of obese dams (Kirk et al., 2009; Walker 
et al., 2008), even though any effect on body weight was offset by other factors. 
However, our results also demonstrate that the preference for high fat foods that has been 
shown in offspring of high fat-fed mothers (Ong and Muhlhausler, 2011; Vucetic et al., 
2010; Walker et al., 2008) is not caused by hyperleptinemia, and may even be prevented 
by it.    
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Adult offspring from dams with hyperleptinemia had reduced weight gain, which 
means that their energy intake to energy expenditure ratio may have been lower than that 
of offspring from control dams. A significant effect on short-term locomotor activity in 
an open field was detected in female offspring from DB/+ dams, but not those from LEP 
dams compared to SAL, despite a numerical difference and a decreasing p-value 
overtime (Table 7). This indicates a possible dose effect, as LEP dams had less severe 
hyperleptinemia compared to their controls, than the DB/+ dams. Higher levels of 
locomotor activity in offspring of hyperleptinemic mothers may have contributed to the 
reduced weight gain and may explain the increase in food consumption, as they have 
higher energy demands. Other studies have also shown an increase in activity from 
offspring from females on high fat diets or have diabetes (Ornoy et al., 1998; Raygada et 
al., 1998; Rizzo et al., 1997a; Zhao et al., 2011). Raygada and others found that high 
intake of polyunsaturated fatty acids, which may be harmful in large amounts (Sultana et 
al., 2003), during pregnancy increased activity level of offspring (Raygada et al., 1998). 
In the rat, offspring of diabetic mothers treated with insulin had higher activity levels 
than either controls or diabetic mothers with poorly controlled glucose, suggesting that it 
is not hyperglycemia that affects offspring activity (Zhao et al., 2011); these mothers are 
hyperleptinemic which may explain the results.  In humans, children of women with 
GDM display higher levels of hyperactivity associated with attention deficit disorder 
(Ornoy et al., 1998; Rizzo et al., 1997a). Although maternal hyperleptinemia is associated 
with high fat diet and diabetes it was not directly looked at in these studies, but it may 
explain the observed increase in offspring activity, which is clearly shown in the current 
study. The increase in activity may also increase energy expenditure. 
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There are many ways energy is expended: reproduction, basal metabolic rate, 
digestion and food processing, and thermoregulation (Garland et al., 2011).   Two other 
major categories are voluntary exercise and spontaneous physical activity (SPA). 
Spontaneous physical activity results in nonexercise activity thermogenesis (NEAT), 
which is the expenditure of energy. There is a balance between daily energy intake and 
daily energy expenditure  and  voluntary exercise and SPA can both play important roles 
in maintaining that balance (Garland et al., 2011).  Humans in developed countries 
generally do not engage in much voluntary exercise, but this could potentially be offset 
by an increase in SPA, and therefore NEAT, if sedentary behaviors are reduced (Garland 
et al., 2011). Studies in both humans and rodents have shown that obese individuals are 
less active than individuals of normal weight and that increased spontaneous physical 
activity  protects against obesity (Johannsen et al., 2008; Levine et al., 2005; Perez-
Leighton et al., 2013b; Teske et al., 2012). Two studies observed spontaneous ambulatory 
activity and posture in lean and obese women and found the lean women sat two or more 
hours less per day than obese women (Johannsen et al., 2008; Levine et al., 2005). One of 
the studies observed that lean women stood two hours more per day and spent twice as 
much time in activity than their obese counterparts (Johannsen et al., 2008). Studies in 
rats have found similar results (Perez-Leighton et al., 2013b; Teske et al., 2012) and have 
linked increased SPA with orexin receptor activation (Perez-Leighton et al., 2013a). 
High-activity rats were resistant to obesity and had higher NEAT, in addition to having 
increased expression of prepro-orexin mRNA and exhibiting more pronounced increase 
in activity when orexin was injected into the rostral lateral hypothalamus (Perez-Leighton 
et al., 2013b).  Altogether, this suggests that increased SPA, and in turn NEAT, maybe 
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sufficient to decrease body weight and can be programmed in offspring; however a more 
comprehensive study is warranted.  
Hyperleptinemia resulted in more consistent increases in activity in female than 
male offspring of hyperleptinemic dams, despite similar protection from overweight in 
the two sexes (Table 7). Maternal hyperleptinemia is likely acting to prevent excessive 
weight gain through other mechanisms, such as increased basal metabolic rate, in male 
offspring.  
Results of the coordinated motor skill and anxiety-related behaviors assays are 
also consistent with an increase in activity in female offspring of hyperleptinemic 
mothers. In the zero-plus maze, there was an increase in exploratory behaviors in male 
offspring of DB/+ mothers, but there were no differences among treatment groups in the 
major measure of anxiety-related behaviors, time spent in the closed arms, suggesting 
that the exploratory behaviors may be more indicative of an overall increase in activity 
levels rather than a decrease in anxiety (Table 7).  On the other hand, the increase in 
activity could be interpreted as an increase in exploratory behavior since they were in a 
novel environment. However, there was no difference in habituation over the 5 minute 
increments of the 30 minute sessions, indicating that exploratory behaviors were not 
different.  Female offspring from hyperleptinemic dams stayed on the rotarod longer than 
their controls on 1 day at 11 weeks of age, which could indicate, rather than a difference 
in motor skills, a difference in physical activity. Alternatively, it could indicate altered 
learning or memory, as only the offspring of DB/+ dams retained the rotarod performance 
gains made between days 1-3 at age 4 weeks through day 1 of testing at age 11 weeks. 
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Effects of maternal hyperleptinemia on offspring learning and memory should be targeted 
in future investigations.  
3.4.4   Lactation Period 
One limitation of our study is that maternal hyperleptinemia may also have 
exerted an effect during the lactation period. In the current study, maternal leptin levels 
were not measured during lactation, therefore it is unknown whether the Leprdb/+ dams 
remained hyperleptinemic after giving birth.  It is reasonable to assume that the females 
with the leptin pumps were hyperleptinemic no more than 5 days postpartum, because the 
pump infusion lasts only 28 days according to the manufacturer. Lactation is a critical 
period of offspring development. In a study where offspring from obesity-resistant rat 
dams were cross fostered with obesity-prone dams, the offspring from obesity-resistant 
dams became obese, insulin resistant and had altered hypothalamic neuropeptides, insulin 
and leptin receptors (Gorski et al., 2006). Offspring raised in small litters during the 
lactation period, giving them access to more milk, become obese and hyperphagic 
(Plagemann et al., 1999). In a study where offspring were exposed to maternal junk food 
diet throughout gestation and lactation or just gestation, offspring exposed during both 
periods became more hyperphagic when on a junk food diet than those from dams on a 
junk food diet during gestation alone (Bayol et al., 2007).  
A possible mechanism for these effects could be due to an alteration in the leptin 
surge that occurs in rats and mice early in the postnatal period (Alfaradhi and Ozanne, 
2011).  This surge is disproportionate to body fat and does not cause weight loss, which 
indicates that the hypothalamus is still developing (Bouret et al., 2004). Leptin has been 
shown to increase axon density and length in the hypothalamus of neonates in vitro, and 
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is suggested to play an important role during this developmental period (Cottrell et al., 
2009). When leptin is injected during early postnatal life it alters the expression of 
neuropeptide Y, agouti related peptide and proopiomelanocortin, which are involved in 
appetite control in the hypothalamus (Proulx et al., 2002). Some studies have shown that 
leptin, consumed at physiological levels during lactation, protects against weight gain, 
leptin and insulin resistance and reduces food consumption and preference for high fat 
foods during adulthood in rats (Pico et al., 2007; Sanchez et al., 2008). Altogether, these 
studies indicate the importance of the lactation period in offspring development and that 
leptin may be a key player during this time. Further investigation needs to be done to 
separate effects of hyperleptinemia during gestation and lactation. 
3.5    Conclusion 
Maternal hyperleptinemia during pregnancy reduces offspring weight gain, even 
after exposure to an obesogenic diet. This is facilitated by an increase in basal activity. 
The increase in energy expenditure results in increased energy intake. To our knowledge, 
this is the first study to show that maternal hyperleptinemia alone, without the 
complications of obesity, diabetes or altered nutrition, programs offspring behavior in 
this manner.  
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